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Abstract 
 
Zoonoses are a significant threat to public health and can also be a considerable 
economic burden. A large proportion of zoonotic pathogens have rodent hosts that 
provide important connections between wildlife communities and humans. This 
thesis aimed to better understand the risk to humans from hantaviruses and Ljungan 
virus in the UK by targeting rodents from urban and semi-rural environments, by 
sampling domesticated pet rats and also by studying brown rats in and around Lyon 
(France). Hantaviruses are zoonotic and cause haemorrhagic fever with renal 
syndrome in Europe, but their presence in the UK had never been confirmed. 
Ljungan virus (LV) has been associated with several human diseases in Europe, but 
has not been confirmed as zoonotic, although it has been detected in rural rodents in 
the UK. All samples were assayed for these viruses using PCR detection methods. 
Moreover, I used high throughput sequencing to quantify genomic variation in two 
new LV genomes to better understand the evolution of this group. I present 
molecular evidence of a novel hantavirus circulating in a rural rodent species within 
the UK, as well as a Rattus–associated hantavirus, Seoul virus, in pet rats in the UK 
and brown rats from Lyon. This study therefore not only adds confirmation of a 
novel hantavirus species circulating in the UK but also that Seoul virus might be 
more prevalent in European brown and pet rats than previously believed. Analyses of 
sequence variation (cytochrome b) of brown rats found few genetic differences, 
irrespective of infection status, country of origin and domestication, and thus could 
not be used to identify whether the introduction of non-indigenous rats into the UK 
is associated with Seoul virus. The prevalence of LV was much lower than that 
previously reported, possibly due to differences in habitat type and the virus‟ 
maintainability. I identified a lack of potential adaptive variation among LV 
genomes perhaps indicative of it being a slow evolving virus, a characteristic unlike 
other RNA viruses. This study has also shown that further surveillance should be 
conducted in the UK, targeting not only the two viruses described here, but also 
existing and novel zoonotic pathogens carried by rodents that have yet to be 
detected. 
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Chapter 1. General Introduction 
 
1.1 Background 
1.1.1 Zoonoses 
Zoonoses as defined by the World Health Organisation (WHO) are diseases and 
infections transmitted naturally between vertebrate animals and man. It has been 
reported that approximately 61 % of all infectious organisms that are known to be 
pathogenic to humans are zoonotic (Taylor et al., 2001). Emerging infectious 
diseases (EID) are defined as diseases that have either appeared for the first time, 
increased in incidence or been reported in new areas or hosts (Cleaveland et al., 
2001). Of 335 EIDs globally reported between 1940-2004, the majority were 
zoonotic and originated from wildlife species (Jones et al., 2008). Examples of 
globally important EIDs include acquired immunodeficiency syndrome (AIDS), 
influenza A (H1N1; Swine flu) and severe acute respiratory syndrome (SARS). 
Zoonoses are not only a significant threat to public health but they can also incur 
considerable economic burden. An example is that of the economic impact of SARS 
in 2002 which cost an estimated US $90 billion worldwide (WHO, 2003). 
 
Factors that have been proposed to explain the emergence of new diseases include 
pathogen evolution (e.g. mutations), host characteristics (e.g. immunosuppression), 
host population characteristics (e.g. size, behaviour, movement) and ecological (e.g. 
agriculture, climate domestication, land use, translocation, urbanisation), but by no 
means are these factors exclusive (Cleaveland et al., 2001; Morris & Potter, 1997; 
Morse, 1995; Schrag & Wiener, 1995). Ecological factors are important, and are 
mostly associated with humans. As such they pose the greatest risk of disease 
emergence as a result of increased animal-human contact, and so the potential for 
increased transmission opportunities (Daszak, 2000; Jones et al., 2008; Mahy & 
Murphy, 1998; Peters et al., 1994). For example human outbreaks of two filoviruses, 
Ebola and Marburg are associated with human encroachment in Africa (Monath, 
1999). Principally for a pathogen to successfully emerge it must first establish itself 
in a new host by jumping the species barrier, it then optimally persists and eventually 
spreads in that host (Morse, 1995). 
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Zoonotic diseases can result from infection with viruses (e.g. Rabies), bacterium 
(e.g. Q fever), macroparasites (e.g. Taeniasis), fungi (e.g. Sporotrichosis) or other 
unconventional agents (e.g. Bovine spongiform encephalopathy). Of these, viruses 
are the major cause of zoonotic infectious diseases and are highly likely to emerge 
(Cleaveland et al., 2001). This is mainly because of the difficulty in treating viral 
diseases but also more importantly they exhibit greater mutation rates and shorter 
generation times than any other pathogen, and RNA viruses in particular have low 
fidelity polymerases (Domingo & Holland, 1997; Holmes, 2003). The transmission 
of such zoonotic organisms to humans can be directly through contact to the animal 
host (e.g. Nipah virus from fruit bats; Chua et al., 2000) or indirectly via ticks (e.g. 
Tick-borne encephalitis virus; Dumpis et al., 1999), mosquitoes (e.g. Chikungunya 
virus; Pialoux et al., 2007), fleas (e.g. Yersinia pestis; Perry & Fetherston, 1997), 
food and water (e.g. Giardia lamblia and Salmonella; Adam, 2001; Newell et al., 
2010) or inhalation of excreta (e.g. Hantavirus; Schmaljohn & Hjelle, 1997). 
 
1.1.2 Rodents as a source 
A large proportion of zoonotic pathogens have rodents as hosts (22.5 %) and are 
only exceeded by pathogens which infect ungulates (cattle, goats, horses, pigs and 
sheep) (39.3 %) and carnivores (cats and dogs) (43 %) (Cleaveland et al., 2001). A 
few important rodent-borne zoonotic pathogens found around the world include 
hantaviruses, Leptospira, lymphocytic choriomeningitis virus (LCMV), Y. pestis and 
Spirillum minus. 
 
Since 2002, at least 33 notifiable or reportable zoonotic pathogens have been 
recorded in either animals or humans within the United Kingdom (UK) (Defra, 
2012). As published in the latest annual report on zoonoses in the UK by the 
Department for Environment, Food & Rural Affairs (DEFRA), 28 of these 33 
zoonotic pathogens were reported as circulating during 2011 (Defra, 2012). 
Organisms such as Crytposporidium sp. (3,600 laboratory-confirmed human cases), 
Camplylobacter sp. (72,000), Borrelia burgdorferi (1,200), Salmonella sp. (9,400) 
and verocytotoxin-producing Escherichia coli (VTEC) (1,400) are the cause of most 
human cases of zoonotic disease in the UK (Defra, 2012). Of these 28, at least five 
zoonoses are known to be associated with rodents including bovine tuberculosis 
(Cavanagh et al., 2002), cryptosporidiosis (Chalmers & Giles, 2010), haemorrhagic 
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fever with renal syndrome (HFRS) (described below) (Jameson et al., 2013a), 
leptospirosis (Ellis, 1999) and Lyme disease (O'Connell, 1995). Two other potential 
zoonoses that are associated with rodents in the UK but are not classified as 
notifiable or reportable include cowpox (Chantrey et al., 1999) and Capillaria 
hepatica (McGarry et al, unpublished data). 
 
A feature of many rodent populations is their fluctuating densities caused by a 
combination of factors; climate, competition, predation and food availability through 
mast years (the production of an exceptional amount of tree fruit in a given year) 
(Davis et al., 2005). With the potential for rodent densities to increase in certain 
years and the already occurring human encroachment and habitat destruction, an 
increase in the relative contact between rodents and humans is expected, thus likely 
increasing the risk of zoonotic pathogen transmission and emergence. 
 
Two important viruses that are of current interest include hantavirus, and Ljungan 
virus; a reported potential zoonosis (Niklasson et al., 1999). Whilst both viruses have 
been reported in Europe there is insufficient evidence reported to also suggest their 
wide circulation within the UK. Within this thesis, using a systematic approach, we 
will investigate the presence and prevalence of these two viruses in UK wildlife. 
 
1.1.3 Hantaviruses 
Hantaviruses (Family Bunyaviridae, genus Hantavirus) are thought to be historically 
responsible for a variety of severe illness outbreaks spanning more than a century 
(Bradford, 1916; Bridson, 2001; Brown, 1916; McKee et al., 1991). However the 
etiological agent had long eluded researchers until an outbreak of Korean 
haemorrhagic fever (KHF) occurred during the Korean War (1950-1953) and was 
accountable for the hospitalisation of more than 3,000 United Nations soldiers. An 
agent was isolated from the striped field mouse (Apodemus agrarius coreae) and 
given the name Hantaan virus (HTNV) (Lee et al., 1978). Since then a further 23 
hantavirus species have been classified by the International Committee on 
Taxonomy of Viruses (ICTV: www.ictvonline.org, date accessed 1/5/13) although 
many more have been proposed. The criteria that currently defines a new hantavirus 
species include having sufficient amino acid sequence diversity in the S and M 
segments (>10 %), detected in a rodent species not previously reported as a host of a 
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hantavirus, and can be differentiated from other hantaviruses by cross-neutralisation 
tests (Maes et al., 2009; Nichol et al., 2005). The genetic relationship of hantaviruses 
cluster according to relatedness of their carrier hosts (Figure 1.1) (Vapalahti et al., 
2003). 
 
 
 
 
 
Figure 1.1. Schematic diagram adapted from Figure 5.3, illustrating the phylogenetic 
relationship of associated hantaviruses within subfamilies.  
 
 
 
The hantaviruses are single stranded negative sense RNA viruses with a genome 
composed of three segments (Fig. 1.2), small (S) (1.7 kb) which encodes the 
nucleocapsid protein, medium (M) (3.5 kb) the glycoprotein and large (L) (6.5 kb) 
the RNA polymerase. Hantaviruses have been found circulating in rodents, 
insectivores and bats (Klempa et al., 2007; Weiss et al., 2012) and are primarily 
transmitted directly from the carrier via the inhalation of virus contaminated urine 
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and faeces. Rodents have been shown to have a chronic life-long infection however 
show no signs of disease. In contrast the virus in humans causes two severe clinical 
manifestations; 1) hantavirus cardiopulmonary syndrome (HCPS) mainly restricted 
to the Americas and responsible for 200 cases a year and causing mortality of up to 
40 % (Bi et al., 2008); 2) haemorrhagic fever with renal syndrome (HFRS) which is 
mainly restricted to Eurasia and responsible for 150,000-200,000 human cases each 
year and causing mortality of up to 12 % (Bi et al., 2008; Vaheri et al., 2012). 
Within Europe there are five established rodent-borne hantaviruses known to be 
circulating (Table 1.1). 
 
 
 
 
 
 
Figure 1.2. Schematic diagram of the tri-segmented hantavirus genome illustrating 
its organisation. The large (L) segment encodes the RNA polymerase, the medium 
(M) segment encodes the glycoproteins and the small (S) segment encodes the 
nucleocapsid protein. Approximate lengths (nucleotides) of each segment are shown. 
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    Table 1.1. Hantavirus species known to be circulating in Europe, their rodent host, virus distribution and severity of HFRS disease caused. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Virus distribution (Olsson et al., 2010), 
2
HFRS disease (Vaheri et al., 2012) 
 
 
 
Hantavirus Rodent host species Virus distribution
1 
HFRS severity
2 
References 
Dobrava-Belgrade (DOBV) 
Yellow-necked mouse (Apodemus 
flavicollis) 
Central and eastern 
Europe 
Severe 
(Avsic-Zupanc et al., 
1992) 
Puumala (PUUV) Bank vole (Myodes glareolus) Widespread Mild 
(Brummer-
Korvenkontio et al., 
1980) 
Saaremaa (SAAV) Striped field mouse (A. agrarius) 
Central and eastern 
Europe 
Mild 
(Plyusnin et al., 
1997b) 
Seoul (SEOV) 
Black rat (Rattus rattus), brown rat     
(Rattus norvegicus) 
Belgium, Ireland, 
France, Portugal, and 
UK. 
Moderate 
(Heyman et al., 
2004) 
Tula (TULV) Common vole (Microtus arvalis) 
Central and eastern 
Europe 
Unknown 
(Plyusnin et al., 
1994) 
1
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Tropism of hantaviruses (pathogenic and non-pathogenic) in both humans and 
rodents is thought to be the same; primarily targeting the endothelial cells and 
macrophages of the lungs and kidneys (Green et al., 1998; Lee et al., 1981; Maes et 
al., 2004; Yanagihara, 1990; Yanagihara et al., 1985), although it remains unclear as 
to why rodents remain persistently infected yet do not generally exhibit any ill effect 
on health (Lee et al., 1981; Meyer & Schmaljohn, 2000; Vaheri et al., 2008; 
Yanagihara et al., 1985). The severity of disease is generally dependent on the 
hantavirus involved, though variations in symptoms and severity within a species 
have been observed (Kanerva et al., 1996; Mentel et al., 1999; Peters et al., 1999; 
Pilaski et al., 1994; Vaheri et al., 2012). The extent of endothelial permeability is 
thought to be a key factor in determining the severity of disease (Gavrilovskaya et 
al., 2012; Maes et al., 2004; Muranyi et al., 2005; Vapalahti et al., 2003). A genetic 
predisposition related to the type of human leukocyte antigen (HLA), a human 
equivalent to the major histocompatiability complex (MHC) has also been found to 
be a key factor in the severity of HV disease course (Kilpatrick et al., 2004; 
Mustonen et al., 1996). The full extent as to why some hantaviruses are pathogenic 
and others are not, is not fully understood however it is known that there are at least 
two requirements necessary for hantaviruses to be pathogenic; the ability to regulate 
an early interferon response and the use of specific integrins (Alff et al., 2006; Alff 
et al., 2008; Gavrilovskaya et al., 2012; Gavrilovskaya et al., 1999; Gavrilovskaya et 
al., 1998; Geimonen et al., 2002; Matthys et al., 2011; Matthys et al., 2010; 
Raymond et al., 2005). Ultimately however the complete mechanisms behind why 
some hantavirus species are pathogenic and some are not, why some produce more 
severe disease than others, or why some exhibit primarily pulmonary rather than 
renal symptoms, remains to be determined and requires further research. 
  
Dobrava-Belgrade virus (DOBV) and Puumala virus (PUUV), the causes of the most 
severe and mildest HFRS disease in Europe, respectively, are prevalent and thought 
to be responsible for the majority of human HV cases. Saaremaa virus (SAAV), 
Seoul virus (SEOV) and Tula virus (TULV) however show a low prevalence, and 
especially in the case of Seoul virus, sporadic, in Europe (Heyman et al., 2011; 
Vaheri et al., 2012). Numbers of human hantavirus infections in Europe are reported 
to be on the rise (Heyman et al., 2011; Vaheri et al., 2012). The recent increase in 
awareness and improvement in diagnostics goes some way to explaining this 
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(Heyman et al., 2011; Reusken & Heyman, 2013). However other factors that could 
be the cause of the increased emergence of cases in Europe include aspects such as 
reservoir ecology (Tersago et al., 2009), virus ecology (Hardestam et al., 2007; 
Kallio et al., 2006) and anthropogenic factors (Heyman et al., 2012; Makary et al., 
2010; Mertens et al., 2011; Reusken & Heyman, 2013; Vapalahti et al., 2010). 
 
Currently there are no reliable treatments available for hantavirus disease in humans 
however there have been trials using formalin–inactivated vaccines such as 
Hantavax® (Cho & Howard, 1999; Cho et al., 2002; Hjelle, 2002; Johnson, 2001; 
Lee et al., 1999), recombinant vaccines (Spik et al., 2008) and antivirals such as 
Ribavirin (Bai et al., 1997; Huggins et al., 1991; Huggins et al., 1986; Rusnak et al., 
2009; Severson et al., 2003) with moderate success. At present the best course of 
treatment is supportive, specifically maintaining internal fluid balance (Vapalahti et 
al., 2003). Once a patient is hospitalised, the need for treatment to reduce virus 
replication is too late and often no longer required, therefore breaking the 
transmission cycle is critical (Heyman et al., 2009b). As such the best approach is 
preventing contact with rodents and their aerosolised excretions, and includes rodent 
control, rodent-proofing housing and food storage, and precautions to prevent the 
inhalation of aerosolised virus (Vapalahti et al., 2003). Proposed risk factors for 
acquiring hantavirus infection include professions that may come into contact with 
rodents, cigarette smokers, and men more than women (Abu Sin et al., 2007; Ahlm 
et al., 1998; Makary et al., 2010; Vapalahti et al., 1999; Vapalahti et al., 2010). 
 
1.1.3.1 Hantavirus in humans in the UK 
There have been very few human hantavirus cases reported in the UK. In the 
majority of instances the causative virus species was not confirmed in clinical 
specimens and the evidence is at best sporadic and highly insufficient in details 
(reviewed in Fhogartaigh et al., 2011; McCaughey & Hart, 2000) (Table 1.2). The 
first recorded human case was in 1983 in a young male from Glasgow who was 
admitted with a clinical presentation suggestive of hantavirus disease and was found 
to have high titres to HTNV antibodies in his serum (Table 1.2) (Walker et al., 
1984). Between this first report and 2010 a further eight individual cases were 
detailed, some sharing symptoms as well as additional ones and even no renal 
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involvement in some cases (Kudesia et al., 1988; Pether et al., 1991; Pether et al., 
1993; Phillips et al., 1991; Rice et al., 1993; Watson et al., 1997) (Table 1.2). These 
cases clearly show an inconsistent clinical picture for HFRS in the UK or possibly 
indicates the presence of more than one hantavirus species circulating. In several 
cases it was noted that rodent exposure coincided with the onset of symptoms and in 
only one case (2010) had a patient travelled abroad suggesting the circulation of an 
indigenous hantavirus within the UK. 
 
Subsequent sero-epidemiological studies of potential at risk groups were conducted; 
involving those coming into close contact with rodents and their faeces/urine (e.g. 
farmers). Whilst many of the studies failed to identify the etiological agent, sero-
prevalences of hantavirus specific antibodies of approximately 1-4.8 % of farmers 
(Coleman, 2000; Davies et al., 1988; Stanford et al., 1990; Thomas et al., 1999) and 
3.5-8.8 % in residents of Somerset (Pether & Lloyd, 1993) have been reported. 
Clinical cases include 2.1 % in patients presenting with HFRS symptoms reported 
from Northern Ireland (NI) (McKenna et al., 1994), and higher seroprevalences have 
been found as a result of laboratory acquired infections in the UK (Lloyd et al., 
1984; Lloyd & Jones, 1986; Smith & Palmer, 1996). The majority of these studies 
included healthy individuals and as such suggests past exposure to hantaviruses and 
consequently a subclinical infection circulating.  
 
Whilst these studies provide compelling evidence of the existence of hantaviruses in 
the UK, they did not confirm which hantavirus species were involved. In each case, 
hantaviral antibodies were detected by immunofluorescence assay (IFA) rather than 
actual virus and in several cases it was not specified exactly which hantavirus 
antigen was tested against. Reports that did describe a specific serotype in the UK 
suggested a Hantaan-like infection (Davies et al., 1988; Walker et al., 1984) and a 
Seoul-like infection (McKenna et al., 1994) implicating R. norvegicus as likely 
sources, as cross-reactivity is common among Murinae-associated hantaviruses. 
Prior to 2012, in all but the lab acquired cases, a hantaviral agent responsible was not 
identified making these cases difficult to validate. This is most likely due to several 
factors, there was no rodent available to test, no molecular tests being employed, 
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difficulties in isolating the virus, difficulties in detecting virus in human cases and 
the cross reactivity between hantaviruses in serological testing. 
 
In 2012, the first confirmation of SEOV RNA in UK brown rats was reported 
(Jameson et al., 2013a). A patient from the Humber region with suspected hantavirus 
disease was confirmed to have high hantavirus antibodies (using HNTV and SEOV 
antigen). Hantavirus RNA was detected in the lungs of two of four brown rats 
trapped at the patient‟s residence. The hantavirus was confirmed as SEOV and 
designated strain Humber (Jameson et al., 2013a). There are several ports situated 
along the Humber estuary that could have facilitated the introduction of SEOV 
infected rats into the UK. Interestingly however genetic analysis of this strain 
confirm it to be most similar to IR461, a strain that was previously responsible for 
UK human laboratory-acquired infections (Jameson et al., 2013a; Shi et al., 2003). 
 
1.1.3.2 Hantavirus in UK rodents and domestic pets 
The UK supports numerous rodent species including several species of mice, rats 
and voles. In 1993 in Somerset following a surveillance of human patients, 
hantavirus antibodies were detected in 4 % brown rats and ~1 % of „mice‟ (Pether & 
Lloyd, 1993). Another study screened a cohort of 127 brown rats from 11 British 
farmsteads, and found five animals were positive for hantavirus antibodies and four 
were reactive to HTNV and one to SEOV (Lloyd, 1991; Webster & Macdonald, 
1995). A study in Northern Ireland detected antibodies to HTNV and SEOV in 
brown rats (21.6 %), wood mice (A. sylvaticus) (3.2 %) and house mice (Mus 
musculus) (28.8 %) (McCaughey et al., 1996). An earlier report had also found 7.4 
% mice to be sero-positive in Northern Ireland (one house mouse and one wood 
mouse) (Davies et al., 1988; Stanford et al., 1990). Despite virus antibodies being 
detected in wild rodents no hantaviral agent had previously been isolated. 
 
In addition, a serological survey of domestic cats in the UK reported the presence of 
hantavirus specific antibodies to HTNV in 15 % of domestic cats and 23 % of 
chronically ill cats (Bennett et al., 1990). More recently human cases of suspected 
hantavirus disease have led to the detection and subsequent isolation of SEOV from 
pet rats in North Wales and Oxfordshire (Jameson et al., 2013b; Taori et al., 2013). 
Both of these studies highlight the public health concern that domestic pets could 
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pose, as closer contact with humans will inevitability result in a greater risk of 
zoonotic disease. 
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Year Location Age Gender Symptoms Diagnostic Test Antigen Antibodies present Ref. 
1983 Glasgow 21 Male Fever, submandibular 
swelling, conjunctivitis, 
erythematous rash. 
 
IFA HTNV IgM & IgG (Walker et 
al., 1984) 
1988 Glasgow 18 Male Fever, abdominal pain, 
headache, haematuria. 
 
IFA - IgG & IgM (?) (Kudesia et 
al., 1988) 
1991 Somerset 42 Male Abdominal pain, enlarged 
spleen and liver, rash, 
arthralgia. 
 
IFA - IgM & IgG (Pether et 
al., 1991) 
1991 Somerset 64 Female Fever, rash, conjunctivitis, 
submandibular swelling, 
enlarged spleen & liver. 
 
IFA - IgM & IgG (Phillips et 
al., 1991) 
1991 Somerset 21 Male Arthropathy, vasculitic 
rash, abdominal pain. 
 
IFA - IgM & IgG (Pether et 
al., 1993) 
1991 Sheffield 16 Female Arthralgia, erythematous 
rash, abdominal pain. 
 
IFA - IgG (Rice et al., 
1993) 
1991 Sheffield 18 Female Abdominal pain, lethargy, 
arthralgia. 
IFA - IgG (Rice et al., 
1993) 
Table 1.2. Summary of the human cases of suspected hantavirus disease in the UK. 
 
2
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a
Recent travel to Estonia 
b
Exposure to same population of pet rats 
     
 
 
    
Year Location Age Gender Symptoms Diagnostic Test Antigen Antibodies present Ref. 
1994 Nottingham 10 Male Nausea, abdominal pain, 
haematuria. 
 
IFA - IgM & IgG (Watson et 
al., 1997) 
2010 London
a
 35 Male Headache, backache, fever, 
myalgia. 
 
IFA PUUV IgG (Fhogartaigh 
et al., 2011) 
2011 Oxfordshire
b 
- Male Acute renal impairment, 
fever, splenomegaly, 
thrombocytopenia. 
 
IFA HTNV & 
SEOV 
IgG (Taori et al., 
2013) 
2012 Yorkshire & 
Humber 
- - Acute kidney injury 
 
 
IFA HTNV & 
SEOV 
IgG (Jameson et 
al., 2013a) 
2012 North Wales
b 
28 Male Acute kidney injury,fever, 
shivers, sweating, 
vomiting, 
 
IFA HTNV & 
SEOV 
IgG (Taori et al., 
2013) 
2013 Oxfordshire
b 
- Female - IFA HTNV & 
SEOV 
IgG (Taori et al., 
2013) 
Table 1.2.  continued. 
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1.1.4 Ljungan virus 
Ljungan virus (LV) (Family Picornaviridae, genus Parechovirus) was the second 
viral species within the parechovirus genus to be discovered and unlike Human 
parechoviruses (HPeV), LV is thought to be zoonotic (Niklasson et al., 1999). Two 
initial lines of evidence led to the discovery of Ljungan virus and its potential impact 
on human health. Firstly, a group of orienteers contracted lethal cases of myocarditis 
in Sweden between 1989-1992, where it was assumed that contact must have been 
made with an etiological agent during path finding competitions (Wesslen et al., 
1992); secondly, human incidences of myocarditis, insulin-dependent diabetes 
mellitus (Type 1) and Guillain-Barré syndrome (GBS) followed the 3- to 4- year 
population fluctuation cycles of bank voles (M. glareolus) in northern Sweden 
(Hansson & Henttonen, 1985; Niklasson et al., 1998). It was hypothesised that these 
diseases could be caused or triggered by an infectious agent carried by bank voles. 
Subsequently, three new parechoviruses were isolated from Swedish bank voles, and 
were named Ljungan virus (referring to the site of isolation). ICTV classify the 
Parechovirus genus in to two distinct species HPeV and LV, LV is then further 
classified into four genotypes, LV87-012, LV174F (gt1) and LV145SL (gt2), 
LVM1146 (gt3) and LV64-7855 (gt4) (Table 1.3). They are single stranded positive 
sense RNA viruses with a genome approximately 7.5 kb and composed of eleven 
proteins (Figure 1.3). 
 
 
 
 
 
Figure 1.3. Schematic diagram illustrating the genomic organisation of Ljungan 
virus. The open reading frame encodes a polyprotein approximately 2,256 amino 
acids (aa) in length and is flanked by a 5‟-untranslated region (UTR) and a 3‟-UTR. 
The polyprotein is made up of 11 individual proteins: VP0 (259 aa), VP3 (244 aa), 
VP1 (297 aa), 2A1 (20 aa), 2A2 (135 aa), 2B (138 aa), 2C (333 aa), 3A (130 aa), 3B 
(29 aa), 3C (198 aa) and 3D (470 aa). Protein lengths are according to prototype 
strain LV87-012 (Accession number AF327920). 
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1.1.4.1 LV in wild animals 
In general, LV appears to have a relatively wide geographical range, having been 
detected in both Europe and America although surveillance is limited. Within 
Europe, LV antibodies and antigens have been detected in Scandinavia in a number 
of rodents including M. glareolus (bank vole) (Niklasson et al., 1998; Niklasson et 
al., 2007a; Niklasson et al., 1999), Myodes rufocanus (grey-sided vole), Microtus 
agrestis (field vole), Lemmus lemmus (Norway lemming), Myopus schistocolor 
(wood lemming) (Niklasson et al., 2006a) and in northern Italy LV RNA has been 
detected in A. flavicollis (yellow-necked mouse) (Hauffe et al., 2010). In 2013, LV 
RNA was also reported in a proportion of rural rodent species, M. glareolus, M. 
agrestis, M. musculus (house mouse) and A. Sylvaticus (wood mouse) in Kielder 
forest, Northumberland UK (Salisbury et al., 2013). In North America, Myodes 
gapperi (southern red-backed vole) and Microtus montanus (montane vole) have 
been reported as hosts for LV (Johansson et al., 2003; Johnson, 1965; Main et al., 
1976; Tolf et al., 2009; Whitney et al., 1970).  LV does not appear to be restricted to 
rodent hosts, as it has been found (diagnostic not specified) in the arctic fox (Vulpes 
lagopus) (Niklasson et al., 2007b) and LV-specific antigens have been found in 
foxes with hydrocephaly (Vulpes vulpes) from the UK (Niklasson unpublished). It 
remains to be determined whether all these potential hosts are capable of acting as 
reservoirs for Ljungan virus. In addition it is possible that additional surveillance for 
LV, which is a relatively recently-described virus, may expand the known 
distribution of this virus and increase the diversity of host species. There are 
currently no data to determine the route of transmission for Ljungan virus, though it 
is proposed to be like that of related parechoviruses (HPeV) and other 
picornaviruses, via the faecal-oral route (McDonald, 2009). However the varied host 
species range exhibited could give support to alternative routes (Niklasson et al., 
2007b).  
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    Table 1.3. Isolation details for the five currently characterised Ljungan virus strains. 
 
 
 
 
 
 
 
 
                                    Isolation  
Genotype Strain Year Location Species Ref. 
      
1 LV87-012 1994 Medelpad County, Sweden Myodes glareolus (Niklasson et al., 1999) 
 
 LV174F 1994 Medelpad County, Sweden Myodes glareolus (Niklasson et al., 1999) 
 
2 LV145SL 1994 Vasterbotten County, Sweden Myodes glareolus (Niklasson et al., 1999) 
 
3 LVM1146 1962 Oregon, USA Microtus montanus (Johansson et al., 2003) 
 
4 LV64-7855 1964/1965 St. Lawrence County, New York, USA Myodes gapperi (Tolf et al., 2009) 
 
2
4
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1.1.4.2 LV and disease 
All current evidence for LV and its pathogenesis disease comes from rodent models. 
Experimental infection of LV in suckling mice produced fatal outcomes (Johansson 
et al., 2003; Niklasson et al., 1999; Niklasson et al., 2006a) and in CD-1 mice LV 
can induce diabetes (Type 1 and Type 2), myocarditis, foetal malformations and 
reproductive problems (Niklasson et al., 2006a; Niklasson et al., 2006b; Samsioe et 
al., 2006). Additionally it is possible that stress plays an important role in the 
development of disease in laboratory rodent models, whereby a combination of virus 
insult and stress induces disease, whilst either stress or virus alone produces little or 
no disease pathology (Niklasson et al., 2003b; Niklasson et al., 2006b; Samsioe et 
al., 2006). Attempts to confirm these results in wild rodents, however, have failed as 
efforts to establish and maintain a pathogen free bank vole colony have been 
unsuccessful (Niklasson et al., 2003b; Niklasson et al., 2006b). Nonetheless, a 
diabetes-like disease similar to that observed in laboratory mice and consistent with 
human type 1 diabetes (Niklasson et al., 2003a) has been reported in several wild 
rodent species (M. rufocanus, M. glareolus, M. agrestis and L. lemmus), both 
directly at capture and after a duration in captivity and this was shown to be 
associated with the presence of LV antigen (Freimanis et al., 2003; Niklasson et al., 
2003a; Niklasson et al., 2003b; Niklasson et al., 2006a; Schoenecker et al., 2000). 
However, to date an unequivocal connection between LV and disease in wild rodents 
has not been confirmed. 
 
1.1.4.3 LV in humans 
While there is presently no evidence confirming Ljungan virus as an etiological 
agent for human diseases, there are strong statistical associations between the bank 
vole population fluctuations (3-4 yr cycles) (Hansson & Henttonen, 1985; Niklasson 
et al., 1998) and the incidences of several human diseases in Sweden - insulin-
dependent diabetes, myocarditis, GBS (Niklasson et al., 1998), intrauterine foetal 
death (IUFD) (Niklasson et al., 2007b), sudden infant death syndrome (SIDS) 
(Niklasson et al., 2009a). There is also evidence of LV antigens and viral RNA being 
detected in specific human disease cases (Niklasson et al., 2009a; Niklasson et al., 
2003a; Niklasson et al., 1999; Niklasson et al., 2009b; Niklasson et al., 2007b). 
Whilst such evidence presents a compelling argument for the involvement of LV in a 
range of human diseases, the validity of some of these reports has been questioned 
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(Kinney & Thach, 2009; Krous & Langlois, 2009; 2010). The evidence for the 
association of LV with SIDs in particular is unconvincing at present due to the small 
number of human cases included in the study, no pathological changes observed in 
the SIDS cases despite identifying the virus, and virus was not found in every SIDS 
case (Kinney & Thach, 2009; Krous & Langlois, 2009). As for other LV human and 
rodent studies, attempts were not made to exclude other potential etiological agents, 
and once again small sample sizes continue to be a concern (Krous & Langlois, 
2010). Nonetheless, due to potential diseases, screening for LV is essential to 
adequately assess the disease associations. 
 
1.2 Methods 
1.2.1 Screening method used in surveillances 
There are two principal methods that can be used in diagnostic virology which have 
already been successfully implemented for both HV and LV detection, nucleic acid 
amplification and serology. The choice of which depends very much on the 
biological question being asked but the merits of each are discussed. 
 
Serological assays involve testing for the presence of virus specific antibodies in 
samples such as serum, cerebrospinal fluid (CSF) and oral fluids, and include 
methods such as enzyme-linked immunosorbant assays (ELISA), virus neutralisation 
assays (vNA) and immunofluorescence assays (IFA). These assays have the 
advantage of being rapid which is of particular use for clinical diagnostic purposes, 
can be used to detect prior (IgG) and recent (IgM) viral exposure, used in place of 
traditional culturing techniques if the virus is difficult to cultivate, and is useful for 
non-invasive sampling i.e. oral fluids (Jeffery & Aarons, 2009). Disadvantages 
include cross-reactivity, poor sensitivity to some viruses, inherent potential for false 
positives, non-specificity of assays meaning the causative virus species cannot be 
distinguished, and these methods are measuring immune response rather than actual 
virus (Jeffery & Aarons, 2009). 
 
Nucleic acid amplification techniques offer an alternative approach to screening and 
in many ways they improve the diagnostic capability compared to that of serological 
tests. Nucleic acid assays such as polymerase chain reaction (PCR) involve the 
amplification of a specific target. They can be used qualitatively and quantitatively 
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in diagnostics, the sensitivity can exceed other diagnostic systems, they are rapid, 
and typing of the target enables the differentiation of virus species (Jeffery & 
Aarons, 2009). These assays can be used on any type of tissue samples unlike 
serology which are restricted to bodily fluids. The main disadvantages to nucleic 
acid methods are that due to the increased sensitivity, there is an inherent risk of 
contamination. Also to design such assays it is essential to have knowledge of the 
target sequence (Jeffery & Aarons, 2009). 
 
Within this thesis rodents will be screened using nucleic acid methods rather than 
serological because of the increased sensitivity, it will enable typing of any 
etiological agent we find but also we are testing multiple tissues which are more 
suitable for the specific detection of each virus species (e.g. kidney, liver or lung). 
The use of tissues rather than blood or urine is more advantageous in this study 
because in terms of hantaviruses the animal may not be shedding the virus or be 
viraemic. With regards to Ljungan virus since we are uncertain of the mode of 
transmission, urine or faeces may not be suitable.  
 
1.2.2 Next Generation Sequencing 
Advances in molecular technologies have led to the development of next generation 
sequencing (NGS) techniques. These have enabled millions of nucleotides to be 
sequenced in a very short time. There are several different chemistries, however, the 
one that will be employed in this thesis is pyrosequencing. Pyrosequencing involves 
a method of „sequencing by synthesis‟ which consists of the release of 
pyrophosphate (PPi) following every nucleotide incorporation, and the subsequent 
conversion via ATP to generate light that is proportional to the number of 
incorporated bases (Radford et al., 2012). There are many applications that NGS 
brings to virology including full genome sequencing, viral quasispecies that could 
lead to resistance and evolution, genome characterisation, and pathogen discovery 
(Radford et al., 2012). NGS enables the rapid collection of genetic information and 
will be used within this thesis to provide a better understanding of both viruses. 
 
1.3  Aim  
This thesis is concerned with the targeted surveillance for hantaviruses and Ljungan 
virus in rodent species from a range of habitats. 
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1.4 Study species 
1.4.1 Rodent species 
Within this study three rodent species were sampled from urban areas, brown rats (R. 
norvegicus), house mice (M. musculus) and wood mice (A. sylvaticus) and three 
from semi-rural environments, bank voles (M. glareolus), field voles (M. agrestis) 
and wood mice (Table 1.4 & Figure 1.4). 
 
Bank voles (M. glareolus) (Figure 1.4a) are found throughout mainland Britain but 
are absent from many offshore islands, and there are an estimated 23 million 
individuals (Harris & Yalden, 2008). These are primarily a diurnal species that 
inhabit woodland, scrubland and hedgerows and their diet mainly consists of grass, 
fruit, seeds and insects. Bank voles have been reported to be infected with PUUV 
and LV on continental Europe (Niklasson et al., 1999; Vaheri et al., 2012) and the 
UK (Salisbury et al., 2013). Whilst they are primarily a rural species, human activity 
may bring them into closer contact and increase the risk from either of these viruses. 
 
Field voles (M. agrestis) (Figure 1.4b) are one of the most numerous mammals of 
mainland Britain, with estimated populations exceeding 75 million (Harris & 
Yalden, 2008). They mainly inhabit ungrazed grassland and are primarily 
herbivorous in their diet. During the summer they tend to be more active during the 
night however in the winter they appear to change to a diurnal lifestyle. Whilst LV 
antibodies and antigens have been detected in field voles in Scandinavia (Niklasson 
et al., 2006a) and LV RNA in the UK (Salisbury et al., 2013), they have not been 
reported as a primary reservoir for hantaviruses, although they have been associated 
with the maintenance of TULV in Germany (Schmidt-Chanasit et al., 2010). 
 
The wood mouse (A. sylvaticus) (Figure 1.4c) can be found in both urban and semi-
rural environments across Britain and Ireland. They are a common and widespread 
species with an estimated population of 38 million (Harris & Yalden, 2008), and 
inhabit a range of habitats. They are generally nocturnal species and have an 
omnivorous diet. The wood mouse has not been reported as a carrier for a hantavirus 
however other members of the Apodemus genus have been associated with DOBV, 
HTNV and SAAV (Avsic-Zupanc et al., 1992; Lee et al., 1978; Plyusnin et al., 
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1997b). Salisbury et al., (2013) published the detection of LV RNA for the first time 
in wood mice and in the UK. 
 
The Norwegian/brown rat (R. norvegicus) (Figure 1.4d) represents a more 
cosmopolitan species having been found on every continent except for Antarctica. Its 
widespread distribution can be attributed to the extensive human movements over 
the past few centuries. Rats are mainly nocturnal and are highly variable in both 
habitat and diet preference and so can be found living in close proximity to humans. 
The brown rat population is estimated at, at least 6 million (Harris & Yalden, 2008). 
Whilst wild brown rats are associated with the distribution of SEOV around the 
world, they have not been reported to be infected with LV. 
 
House mice (M. musculus) (Figure 1.4e) are thought to be the most widely 
distributed mammal after humans, originating from south western Asia, as a result of 
human movements, and as such this species is heavily associated with humans and 
buildings (Cucchi et al., 2005). There are an estimated 5 million house mice in the 
UK (Harris & Yalden, 2008). They tend to be a nocturnal species and have an 
omnivorous diet. Currently hantaviruses have not been detected in house mice 
although their close proximity to humans puts them as a risk. LV RNA has however 
been detected in house mice in the UK (Salisbury et al., 2013).
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Table 1.4. Summary of rodent species included within this study. 
Common name Species 
Food 
preference 
Diurnal/ 
Nocturnal 
Estimated UK 
populations
1 
Rural/ 
Urban 
Previous LV 
infection 
Previous HV 
infection 
Bank vole 
 
 M. glareolus 
 
Omnivorous 
 
Diurnal 
 
23,000,000 
 
Rural 
 
Yes
2,3 
 
PUUV
4 
 
Field vole 
 
M. agrestis 
 
Herbivorous 
 
Annual rhythm: nocturnal 
(summer), diurnal (winter) 
 
75,000,000 
 
Rural 
 
Yes
3,5 
 
Associated 
with TULV
6 
 
Wood mouse 
 
  A. sylvaticus 
 
Omnivorous 
 
Nocturnal 
 
38,000,000 
 
Both 
 
Yes
3 
 
No 
 
Norway (brown) rat 
 
   R. norvegicus 
 
Omnivorous 
 
Nocturnal 
 
6,790,000 Both 
 
No 
 
SEOV
7 
 
House mouse  M. musculus Omnivorous Nocturnal 5,192,000 Urban Yes
3 
No
 
 
1
(Harris & Yalden, 2008),
  2
(Niklasson et al., 1999), 
3
(Salisbury et al., 2013), 
4
(Brummer-Korvenkontio et al., 1980), 
5
(Niklasson et al., 2006a), 
6
(Schmidt-Chanasit et al., 2010), 
7
(Heyman et al., 2004). 
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a) 
b) 
c) 
e) 
d) 
b) 
d) 
Figure 1.4. Rodent study species 
within this investigation, a) bank vole 
M. glareolus, b) field vole M. agrestis 
courtesy of E. Oksanen, c) wood 
mouse A. sylvaticus, d) brown rat R. 
norvegicus courtesy of Ernie Janese, 
and e) the house mouse M musculus 
courtesy of Stephen Dalton. 
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1.5  Chapter outlines 
Chapter 2: Field work 
A large part of this project required the capture of rodents from around urban areas 
of the North West UK.  The aim of Chapter 2 is to provide a record of the trapping 
method used, capture success and problems encountered throughout the trapping 
period. 
 
Chapter 3: Targeted surveillance for Ljungan virus in UK wildlife. 
LV is associated with human diseases and has been detected in several rodent 
species in Sweden, Denmark, Italy, America and the UK. There is also evidence of 
LV circulating in foxes in the UK. The aim of Chapter 3 is to determine if LV is also 
circulating in rodents from the North West UK. 
 
Chapter 4: Molecular characterisation of two new Swedish Ljungan virus isolates, 
LV340 and LV342. 
There are currently five full LV genomes published and yet there remain many 
unanswered questions regarding the virus‟ biology and evolution, by using next-
generation sequencing technology we hope to get a better understanding of this virus 
and to add to the limited genome data currently available. In Chapter 4 using 454 
pyrosequencing we characterise a further two LV isolates. 
 
Chapter 5: Targeted surveillance for hantaviruses in UK wildlife. 
Circulation of a hantavirus species in UK wildlife has only recently been confirmed 
in rats. However it remains to be answered if other rodents are carriers of 
hantaviruses. Chapter 5 screens rodents from semi-rural and urban environments of 
the North West UK for hantaviruses. Based on the evidence we hypothesise to find 
SEOV circulating in rats around the North West. The main reasons for this are that 
Liverpool is a major port and since rat distributions are facilitated by sea travel, 
SEOV may be introduced from endemic countries. SEOV is the cause of a relatively 
moderate form of HFRS which is frequently underreported. The previous UK human 
case reports suggest the potential for SEOV to be circulating throughout the country. 
We might also expect to find PUUV circulating in the UK however previous 
surveillances have not found evidence to suggest so (Henttonen & Bennett, pers. 
comms).  
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Chapter 6: Seoul virus in rats in Rhône-Alpes. 
In France the situation is somewhat different with currently three of the five 
European hantaviruses being confirmed circulating: PUUV, SEOV and TULV 
(Heyman et al., 2011; Heyman et al., 2004; Plyusnina et al., 2007). Prevalence of 
SEOV in rats in France has so far been based on antibody detection (Heyman et al., 
2004) however a prevalence study using a direct detection method (PCR) is required 
to assess the true prevalence in the rodent species to thereby understand the risk of 
transmission to humans. In Chapter 6 in collaboration with the FP7 WildTech project 
we screened brown rats from urban and rural areas of Rhône-Alpes for hantaviruses. 
 
Chapter 7: Pet rats 
Recent reported human hantavirus cases have been associated with pet rats. In this 
chapter we outline the distribution of SEOV RNA in the organs of an infected brown 
rat and the viral distribution of viral RNA in the lung and kidneys of a closed colony 
of 21 breeding rats. 
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Chapter 2. General Methods 
 
2.1 Study sites 
2.1.1 North West, UK 
Animals were caught around the regions of Liverpool, Wirral and Cheshire. 
Trapping in these areas enabled the capture of several rodent species (Figure 1.1), a 
number of which have been reported as carriers for hantaviruses and Ljungan virus 
across Europe. The North West is a particularly good study area due to the multiple 
habitat types found in close proximity including urban (Liverpool), port (Liverpool), 
and semi-rural areas (Cheshire and the Wirral). Liverpool port is situated in the 
North West of England and is the third busiest in the country, and SEOV has been 
detected in several port cities around the world (e.g. (Cueto et al., 2008; Glass et al., 
1994; Ibrahim et al., 1996; Iversson et al., 1994; Reynes et al., 2003; Wu et al., 
2007). It could also facilitate the transportation of other infected non-indigenous 
rodents into the UK. Urban areas are important study locations due to the increased 
human-rodent interactions and subsequent risk. 
 
2.1.2 Rhône-Alpes, France 
A second study area included sites situated in the Rhône-Alpes region of France. 
This was specifically for trapping brown rats (R. norvegicus) as part of the FP7 
WildTech project – Development of a microarray to detect a wide range of rodent-
borne pathogens. This study area was particularly good due to the presence of both 
urban (Lyon) and semi-rural areas just outside of Lyon.  
 
2.2 Field work 
2.2.1 Pest control data 
Prior to commencing field work the Liverpool Local pest control were approached to 
advise on ideal trapping sites around urban areas of Liverpool. They provided rodent 
“call-out” data for internal rats, external rats and mice for each electoral ward. 
Internal rats refer to animals reported within dwellings, external rats outside, and 
mice reports include both internal and external animals.  
 
Analysing this data highlighted several hotspots around Liverpool that exhibited 
relatively large proportions of rodent call-outs (Figure 2.1). Some of the wards had 
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consistently high call-outs for all three types of rodents. It was also the perception of 
allotment holders and the local pest control that rodent populations have been 
increasing. However, this was not observed for either internal or external rats over 
seven years of data, rather numbers seem to be declining. Potential population 
fluctuation cycles of mice may be present as seen in the mice call-out data (Table 
2.1). Absence of cycles may be as a result of animals being in a fragmented urban 
environment. This general lack of cycles meant we could not make associations with 
the limited human disease data that we had. It did however draw attention to 
seasonal changes suggesting that call-outs did appear to reduce between October and 
December suggesting them as potentially sub-optimal trapping times of the year. 
 
Table 2.1. Total rodent call-outs for the Liverpool area, over seven years (April 
2006-March 2013). 
 
 
Total call-outs 
Year            
(April-March) 
Rats Internal Rats External Mice 
2006-2007 2495 4420 3042 
2007-2008 2583 4183 3157 
2008-2009 2600 4403 3426 
2009-2010 2432 3785 3291 
2010-2011 1948 3592 3053 
2011-2012 1970 3252 3194 
2012-2013 1860 3195 3368 
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Figure 2.1. Spatial change in frequency of rodent call-outs reported to the Local pest control over the time period April 2008-March 2010, a) 
internal rats, b) external rats and c) mice. Colour charts represent the frequency of rodents per 1000 people. 
Q1 Apr - Jun Q2 Jul - Sep Q3 Oct - Dec Q4 Jan - Mar 
a) 2008 /2009 
2009 /2010 
2010 /2011 
3
6
 
  
42 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q1 Apr - Jun Q2 Jul - Sep Q3 Oct - Dec Q4 Jan - Mar 
b) 2008 /2009 
2009 /2010 
2010 /2011 
3
7
 
Figure 2.1. continued. 
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Q1 Apr - Jun Q2 Jul - Sep Q3 Oct - Dec Q4 Jan - Mar 
c) 2008 /2009 
2009 /2010 
2010 /2011 
3
8
 
Figure 2.1. continued. 
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The rodent call-out data is the only indicator of rodent abundance fluctuations within 
an urban environment. However the data is subjective; there is a different response 
from the local pest control depending on whether the animal reported is indoors or 
outdoors and whether it is a rat or a mouse (level of importance: internal rats > 
external rats > mice), and errors could arise in mis-identification or public awareness 
of the preferential treatment. The data does not take into account numbers, as a call-
out just refers to a single data point. Electoral wards with low rodent call-outs could 
be a result of an underreporting of such rodent problems due to the bad social 
connotations that come with it rather than there actually being less rodents there.  
 
This evidence was useful in highlighting that previous word of mouth indications of 
the numbers of rodents increasing over the past few years does not seem to be the 
case. The Local pest control were also approached to assist in providing animals for 
the project however since their strategy is to poison rather than trap they were unable 
to provide us with any samples. Also their customers are mainly business contracts 
and domestic homes who want the animals regarded as pests, removed quickly rather 
than trapped, which would take longer. 
 
2.2.2 Rodent trapping 
Field work was carried out between October 2009 - August 2011. Field sites were 
identified on the criteria of being within an urban environment; having easy access; 
out of direct public attention; and having experienced recent or current rodent 
activity. The majority of sites included allotments as they are good small sites 
surrounded by urbanised areas that are out of the way of the majority of the public. 
Animals were caught using 14” wire cages (Figure 2.2a) for the rats and Longworth 
small mammal traps (Figure 2.2b) for the mice. Nine sites were located around urban 
areas of Merseyside (Figure 2.3 & Table 2.2). In total 329 animals were caught 
consisting of brown rats (Rattus norvegicus), house mice (Mus musculus) and wood 
mice (Apodemus sylvaticus) (Table 2.3). Once caught recordings were taken for 
weight (g), gender, age estimate (Juvenile, sub-adult, adult) and any significant 
observations. Animals were humanely euthanised in the field by the inhalation of the 
anaesthetic, Isoflurane, following UK Home Office Guidelines. 
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Figure 2.2. In situ images of the two traps that were used within this study, a) 14” 
wire cages, and b) Longworth small mammal traps. 
 
Trapping was generally carried out Monday to Friday with a total of four trapping 
nights a week, and 156 trapping nights for the entire study period. With a total of 
329 animals, the trapping rate was approximately 2.1 animals a day. 
 
Table 2.2. Locations of each of the nine field sites. 
 
Site Longitude Latitude Description 
Greenbank 53°23'10.12''N 2°55'47.9''W Urban allotment 
Lister drive 53°25'14.4''N 2°55'56.6''W Urban allotment 
Liverpool port 53°26'27.0''N 3°00'36.7''W Port 
Seeds lane 53°28'13.3''N 2°56'32.2''W Urban allotment 
Sefton 53°23'11.18''N 2°55'57.14''W Urban allotment 
Southport 53°39'15.9''N 3°00'42.9''W Recreational area 
Sudley Drive 53°22'13.81''N 2°55'19.90''W Urban allotment 
Thingwall 53°23'58.0''N 2°54'29.3''W Urban allotment 
University of Liverpool 53°24'24.7''N 2°57'44.2''W Campus 
 
 
 
 
b) a) 
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     Figure 2.3. The location of the trapping sites within a) United Kingdom and b)   
     North West England (sites marked by spots).  
 
Table 2.3. Number of each rodent species caught at each of the nine field sites. 
Site 
Brown rat        
(R. norvegicus) 
House mouse 
(M. musculus) 
Wood mouse 
(A. sylvaticus) 
Total 
Greenbank 30 3 34 67 
Lister drive 15 12 37 66 
Liverpool port 15 0 5 20 
Seeds lane 44 10 38 92 
Sefton 4 0 28 32 
Southport 2 0 0 2 
Sudley Drive 5 0 16 21 
Thingwall 4 5 7 16 
University of Liverpool  10 5 0 15 
Total 129 35 165 329 
 
 
Several problems were encountered with the trapping of small mammals in urban 
areas.  
 
a) b) 
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1) Often there were sites which were recommended as potential trapping locations 
which had in the past experienced rodent activity. After further investigation and 
unsuccessful preliminary trapping nights, it was determined that for the benefits 
of trapping to exceed the time and financial costs, the site had to either be 
experiencing rodent activity at that time or had clear evidence of very recent 
activity e.g. clear runs and/or nests (Figure 2.4). 
2) The accidental catching of other animals in traps also occurred on several 
occasions. This was most likely due to the types of bait being used that enticed 
other animals such as hedgehogs, magpies and brown birds, and the easy food 
source it provided. Bait and trap locations had to therefore be optimised to reduce 
by-catch. 
3) Rats, in particular adults, are neophobic which means that they are fearful of new 
objects, this often placed delays on trapping as traps ideally had to be left open 
for a week prior to trapping and could not be moved to a new location without 
having to incur further delays. 
4) A variety of baits had to be trialled that would encourage the attraction of rats. 
The bait had to be stable for as long as possible under different weather 
conditions, trigger the trap when taken and still be enticing to rats. Trialled baits 
included corn, grain, peanut butter, chocolate, smoked sausage, spam and tuna. 
The optimum bait was a slice of smoked sausage, this not only could be hooked 
on the trap to trigger it once the bait had been taken, but also it did not dry out 
too quickly and did not wash away following rain, it produced a strong aroma 
and it resulted in less by-catch compared to other baits. 
 
2.2.3 Semi-rural rodents 
To enhance sample sizes, additional rodents (n = 166) consisting of brown rats 
(Rattus norvegicus) (n = 4), wood mice (A. sylvaticus) (n = 104), bank voles 
(Myodes glareolus) (n = 50) and field voles (Microtus agrestis) (n = 8) were caught 
around semi-rural areas (Chester and Wirral). These samples were provided through 
collaborations with Chris Ball, Dr. Nicola Williams, Susan Withenshaw, Becci 
Barber, Dr. Niamh Quinn and Giovanni Pellegrini 
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2.3 Post mortems 
Carcases from 23 of 129 (17.8 %) brown rats caught around urban areas of Liverpool 
were provided to Dr Udo Hetzel and Dr John McGarry (University of Liverpool) for 
the purpose of performing post mortems to find signs of pathological disease that 
could indicate to hantavirus or Ljungan virus infections (Appendix 1). The cohort 
was comprised of 11 males and 12 females. Due to financial constraints more rats 
were not included. 
 
On post mortem analysis all 23 animals appeared to be „healthy‟ with no histological 
abnormalities to suggest either hantavirus or Ljungan virus infections. However, 
helminths were observed in 15 animals (65.2 %). Identified helminths include 
Trichosomoides crassicauda in six animals (26.1 %), Mastophorus muris in three 
animals (13.0 %) and the zoonotic nematode Capillaria hepatica in at least two 
animals (8.7 %). 
 
 
 
  
44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Figure 2.4. Examples illustrating signs of rodent activity, a) a run and b) a nest. 
a) b) 
4
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Chapter 3. Ljungan virus surveillance 
 
3.1 Abstract 
Ljungan virus (LV) (family Picornaviridae, genus Parechovirus) are single-stranded 
RNA viruses. LV has been detected in several rodent species and has been shown to 
induce disease in laboratory rodent models. In humans however there are currently 
only associations between LV and human incidences of several diseases in Sweden. 
Previous surveillance has demonstrated the presence of LV RNA in rural rodents in 
Northumberland, North East UK. Between September 2009 and November 2011, 
wild rodents consisting of brown rats (Rattus norvegicus), wood mice (A. sylvaticus), 
house mice (Mus musculus), bank voles (Myodes glareolus) and field voles 
(Microtus agrestis) were live caught across North West England (Cheshire, 
Liverpool and Wirral). Animals were screened using an in house optimised hemi-
nested RT-PCR targeting the 5‟ UTR region. LV RNA was not detected in any of the 
495 rodents tested. Validation and quality assurance panels confirmed the sensitivity 
and specificity of this assay for the purpose of rodent surveillances. Our findings and 
the detection of LV in rural rodents from a previous study suggest that LV may not 
be a major human health concern in urban areas. However with further human 
encroachment this situation might change. 
 
3.2 Introduction 
Ljungan virus (LV) (family Picornaviridae, genus Parechovirus) is a potentially 
serious zoonosis that has associations with several human diseases (McDonald, 
2009). While a direct causative link between Ljungan virus and human disease has 
not yet been established, continued surveillance for this virus remains important. 
 
As previously outlined, two initial lines of evidence led to the discovery of Ljungan 
virus and its potential impact on human health. Firstly, a group of orienteers 
contracted lethal cases of myocarditis in Sweden between 1989-1992, where it was 
assumed that contact must have been made with an etiological agent during path 
finding competitions (Wesslen et al., 1992); secondly, human incidences of 
myocarditis, insulin-dependent diabetes mellitus (Type 1) and Guillain-Barré 
syndrome (GBS) followed the 3- to 4- year population fluctuation cycles of bank 
voles (Myodes glareolus) in northern Sweden (Hansson & Henttonen, 1985; 
5 
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Niklasson et al., 1998). It was hypothesised that these diseases could be caused or 
triggered by an infectious agent carried by bank voles.  Subsequently, three new 
parechoviruses were isolated from Swedish bank voles, and were named Ljungan 
virus (referring to the site of isolation) strain 87-012, 174F and 145SL (Niklasson et 
al., 1999).  A further four LV isolates have been found, two from North America 
LVM1146 (Johansson et al., 2003) and LV64-7855 (Tolf et al., 2009), and two from 
Sweden, LV340 and LV342 (Chapter 4). 
 
Ljungan virus is a single stranded positive sense RNA virus, whose genome is 
approximately 7.5 kb nucleotides (nt). The seven whole LV genomes so far 
described cluster into four “genotypes” (Tolf et al., 2009): LV87-012 and LV174F 
(gt 1), LV145SL, LV340 and LV342 (gt 2) (Johansson et al., 2002) (Chapter 3), 
LVM1146 (gt 3) (Johansson et al., 2003) and LV64-7855 (gt 4) (Tolf et al., 2009). 
Presently gt 1 and 2 have been confirmed in bank voles in Europe whilst gt 3 and 4 
have been found in two different vole species in America. Ultimately, however, little 
is known as to the host specificity and distributions of each LV. 
 
In general, LV appears to have a relatively wide geographical range, having been 
detected in both Europe and America although surveillance is limited. Within 
Europe, LV antibodies and antigens have been detected in Scandinavia in a number 
of rodents including M. glareolus (bank vole) (Niklasson et al., 1998; Niklasson et 
al., 2007a; Niklasson et al., 1999), Myodes rufocanus (grey-sided vole), Microtus 
agrestis (field vole), Lemmus lemmus (Norway lemming), Myopus schistocolor 
(wood lemming) (Niklasson et al., 2006a) and in northern Italy LV RNA has been 
detected in Apodemus flavicollis (yellow-necked mouse) (Hauffe et al., 2010). In 
2013, LV RNA was also reported in a proportion of rural rodent species, M. 
glareolus, M. agrestis, Mus musculus (house mouse) and Apodemus Sylvaticus 
(wood mouse) in Kielder forest, Northumberland UK (Salisbury et al., 2013). In 
North America, Myodes gapperi (southern red-backed vole) and Microtus montanus 
(montane vole) have been reported as hosts for LV (Johansson et al., 2003; Johnson, 
1965; Main et al., 1976; Tolf et al., 2009; Whitney et al., 1970). LV does not appear 
to be restricted to rodent hosts, as it has been found (diagnostic not specified) in the 
arctic fox (Vulpes lagopus) (Niklasson et al., 2007b) and LV-specific antigens have 
been found in foxes with hydrocephaly (Vulpes vulpes) from the UK (Niklasson 
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unpublished). It remains to be determined whether all these potential hosts are 
capable of acting as reservoirs for Ljungan virus. In addition it is possible that 
additional surveillance for LV, which is a relatively recently-described virus, may 
expand the known distribution of this virus and increase the diversity of host species. 
There are currently no data to determine the route of transmission for Ljungan virus, 
though it is proposed to be like that of related parechoviruses (HPeV) and other 
picornaviruses, via the faecal-oral route (McDonald, 2009). However the varied host 
species range exhibited could give support to alternative routes (Niklasson et al., 
2007b). 
 
All current evidence for LV and its pathogenesis disease comes from rodent models. 
Experimental infection of LV in suckling mice produced fatal outcomes (Johansson 
et al., 2003; Niklasson et al., 1999; Niklasson et al., 2006a) and in CD-1 mice LV 
can induce diabetes (Type 1 and Type 2), myocarditis, foetal malformations and 
reproductive problems (Niklasson et al., 2006a; Niklasson et al., 2006b; Samsioe et 
al., 2006). Additionally, it is possible that stress plays an important role in the 
development of disease in laboratory rodent models, whereby a combination of virus 
insult and stress induces disease, whilst either stress or virus alone produces little or 
no disease pathology (Niklasson et al., 2003b; Niklasson et al., 2006b; Samsioe et 
al., 2006). Attempts to confirm these results in wild rodents, however, have failed as 
efforts to establish and maintain a pathogen free bank vole colony have been 
unsuccessful (Niklasson et al., 2003b; Niklasson et al., 2006b). Nonetheless, a 
diabetes-like disease similar to that observed in laboratory mice and consistent with 
human type 1 diabetes (Niklasson et al., 2003a) has been reported in several wild 
rodent species (M. rufocanus, M. glareolus, M. agrestis and L. lemmus), both 
directly at capture and after a duration in captivity and this was shown to be 
associated with the presence of LV antigen (Freimanis et al., 2003; Niklasson et al., 
2003a; Niklasson et al., 2003b; Niklasson et al., 2006a; Schoenecker et al., 2000). 
However, to date an unequivocal connection between LV and disease in wild rodents 
has not been confirmed. 
 
While there is presently no evidence confirming Ljungan virus as an etiological 
agent for human diseases, there are strong statistical associations between the bank 
vole population fluctuations (3-4 yr cycles) in Sweden (Hansson & Henttonen, 1985; 
7
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Niklasson et al., 1998) and the incidences of several human diseases in Sweden - 
insulin-dependent diabetes, myocarditis, GBS (Niklasson et al., 1998), intrauterine 
foetal death (IUFD) (Niklasson et al., 2007b), sudden infant death syndrome (SIDS) 
(Niklasson et al., 2009a). There is also evidence of LV antigens and viral RNA being 
detected in specific human disease cases (Niklasson et al., 2009a; Niklasson et al., 
2003a; Niklasson et al., 1999; Niklasson et al., 2009b; Niklasson et al., 2007b). 
Whilst such evidence presents a compelling argument for the involvement of LV and 
a range of human diseases, the validity of some of these reports has been questioned 
(Kinney & Thach, 2009; Krous & Langlois, 2009; 2010). The evidence for the 
association of LV with SIDs in particular is unconvincing at present due to the small 
number of human cases included in the study, no pathological changes observed in 
the SIDS cases despite identifying the virus, and virus was not found in every SIDS 
case (Kinney & Thach, 2009; Krous & Langlois, 2009). As for other LV human and 
rodent studies, attempts were not made to exclude other potential etiological agents, 
and once again small sample sizes may not be statistically valid (Krous & Langlois, 
2010).  Nonetheless, due to potential diseases, screening for LV is essential to 
adequately assess the diseases associations. 
 
Serological and molecular detection methods have been used for LV diagnosis 
including polymerase chain reaction (PCR), indirect immunofluorescence assays 
(IFA) and immunohistochemistry (IHC) (Mantke et al., 2007; Niklasson et al., 1999; 
Niklasson et al., 2007b). PCR-based methods of detection are frequently used for 
diagnosis, primarily due to the advantage of speed, but also as they can be inherently 
more sensitive than other diagnostic methods (Johansson et al., 2004; Nix et al., 
2008). This sensitivity might be particularly important for LV where low viral copy 
numbers might be characteristic of LV infections (Hauffe et al., 2010; Samsioe et 
al., 2009) (Niklasson unpublished data). PCR-based methods also enabled LV to be 
detected more than 6 months post viral exposure, whilst the antibody response to the 
virus can be inconsistent, weak or even absent in chronically-infected animals 
(Niklasson et al., 1999; Samsioe et al., 2008). Furthermore PCR provides a useful 
tool for investigating LV infection in detail, particularly tissue tropism and 
pathogenesis (Mantke et al., 2007). 
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PCR-based diagnostic methods for LV currently include two published assays that 
amplify the 5‟ untranslated region (UTR), a parechovirus 5‟UTR real-time assay 
(Nix et al., 2008) and an LV specific real-time RT-PCR (Mantke et al., 2007). The 
5‟UTR is a section of the genome situated at the 5‟ end of the mRNA that is not 
translated into protein but is involved in the initiation of transcription. A third hemi-
/nested parechovirus-specific VP1 RT-PCR has recently been published (Nix et al., 
2010) targeting the VP1 gene. Both the VP1 and 5‟UTR regions show some degree 
of sequence conservation making them suitable targets for primers. Both real-time 
assays incorporate Taqman chemistries which utilise a probe along with the primer 
pair to successfully amplify target sequences, this has the benefit of increased 
specificity. The hemi-/nested approach improves the sensitivity of assays by having 
two rounds of amplification. All three assays have been shown to detect all four LV 
genotypes with viral copy detection limits of 100, 60, and 10 for the parechovirus 
5‟UTR real-time assay (Nix et al., 2008), hemi-/nested parechovirus-specific VP1 
RT-PCR (Nix et al., 2010) and the LV specific assays (Mantke et al., 2007), 
respectively. LV has previously been detected in the UK (Salisbury et al., 2013) 
however there is currently little sequence information available and as such it cannot 
be concluded exactly how different indigenous LV strains are to the others. 
Furthermore the two current assays designed to detect all parechoviruses as a 
consequence require a considerable amount of primer degeneracy that could affect 
LV detection. To this end I modified the two assays targeting the 5‟UTR (Mantke et 
al., 2007; Nix et al., 2008), by removing the Taqman probe of the LV specific assay 
to reduce the specificity. With the aim of increasing the sensitivity of the assay, 
primers were combined from both to create a hemi-nested approach. First round 
primer set followed by a second round set using one new internal primer and one 
from the first round PCR. The reverse primer (AN344) (Nix et al., 2008) was 
combined with the forward primer (LVF) (Mantke et al., 2007) in the first round 
PCR, followed by the nesting of the forward and reverse primers (LVF and LVR) 
(Mantke et al., 2007) in the second round. 
 
Given the importance of LV as a potentially important zoonosis it is crucial to 
expand the scope of LV screening. At present, urban rodents have never been 
assessed for LV and it is here where the close proximity to humans will present a 
higher risk. This chapter aims therefore to provide an initial indicator of whether 
9
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Ljungan virus is circulating in wild rodents around the North West UK, both from 
urban and semi-rural environments. I also introduce a hemi-nested RT-PCR that 
combines the primers of two published real-time PCRs, targeting the 5‟UTR of 
parechoviruses (Nix et al., 2008) and Ljungan virus (Mantke et al., 2007) in the aim 
of successfully identifying Ljungan virus in rodents from the North West UK. 
 
3.3 Methods 
Field Work 
Rodents (n = 495) consisting of brown rats (R. norvegicus) (n = 133), wood mice (A. 
sylvaticus) (n = 269), bank voles (M. glareolus) (n = 50), house mice (M. musculus) 
(n = 35) and field voles (M. agrestis) (n = 8) were live-caught across North West 
England (particularly in and around Liverpool, Chester and Wirral, see Chapter 2). 
Animals were humanely euthanised in the field by the inhalation of the anaesthetic, 
Isoflurane, following UK Home Office Guidelines. Most liver tissues were removed 
within 2 hours of euthanasia, but where this was not possible the carcasses were 
stored at -80 °C until processing. All liver samples were stored at -80 °C. 
 
Brain material from one field vole (M. agrestis) (F174) from Kielder forest, 
Northumberland was available for screening using this assay. This sample was 
previously found positive in a separate study (Salisbury et al., 2013). This sample 
was treated in the same way as all the others.  
 
A small cohort (n = 50) of wild fox (V. vulpes) livers were provided by The Food 
and Environment Research Agency (FERA). 
 
RNA extraction  
50-100 mg of liver tissue was homogenised in 1 ml TRIzol® Reagent (Invitrogen, 
Life Technologies, Paisley, UK) with QIAGEN Stainless steel beads (5mm) using a 
QIAGEN TissueLyser (Qiagen, UK) for 2 mins at 30 Hz. RNA was extracted from 
the homogenate as described in the Invitrogen TRIzol® Reagent instructions for 
animal tissues (Invitrogen, Life Technologies, Paisley, UK). The RNA was diluted 
1:10 in sterile distilled water and quantified using a NanoDrop ND-1000 
spectrophotometer (LabTech International, UK) and stored at -80 °C until reverse 
transcription.  
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Reverse Transcription 
RNA was reverse transcribed following a standard first strand cDNA synthesis 
protocol (Invitrogen, Life Technologies, Paisley, UK). Briefly, RNA (>1 µg) was 
reverse transcribed in a 20 µl reaction containing 50 ng/µl random hexamers, 10 mM 
dNTP mix (10 mM each of dATP, dGTP, dCTP and dTTP at neutral pH), 5X First 
strand buffer, 0.1 M DTT and 200 U SuperScript™ III Reverse Transcriptase 
(Invitrogen, Life Technologies, Paisley, UK). Cycling parameters were 65 °C for 5 
mins, 50 °C for 60 mins and 70 °C for 15 mins in a Techne TC-5000 Thermal 
Cycler. The cDNA was stored at -20 °C. 
 
PCR detection 
Two µl of cDNA was PCR-amplified in a 14.5 µl reaction volume containing 75 
mM Tris-HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01 % (v/v) Tween 20, 0.2 mM each 
dNTP, 1.5 mM MgCl2, 0.025 U Taq polymerase (ABgene) and 10 pM (each) of the 
forward and reverse primers (Eurofins MWG Operon, Germany) (Table 3.1). 
Cycling parameters were 95 °C for 10 mins, 20 three step cycles (30 s at 94 °C, 30 s 
at 60 °C, 30 s at 72 °C) and 72 °C for 5 mins. 
 
Table 3.1. Forward and reverse primers used in each step of the nested PCR. 
 
 Primers 
  Forward
 
Reverse
 
First 
round 
LV Forward
a
 (239-257
c
) AN344
b
 (590-611
c
) 
(5‟-GCGGTCCCACTCTTCACAG- 3‟) (5‟-GGCCCCWGRTCAGATCCAYAGT-3‟)d 
Second 
round 
LV Forward
 
LV Reverse
a
 (405-425
c
) 
(5‟- GCGGTCCCACTCTTCACAG –3‟) (5‟- GCCCAGAGGCTAGTGTTACCA-3‟) 
 
   
a. Primers from (Mantke et al., 2007) 
b. Primers from (Nix et al., 2008) 
c. Positions are relative to the genome of LV87-012 complete genome (GenBank accession number AF327920). 
d. Ambiguity codes: R, A or G; Y, C or T  and W, A or T. 
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The second round PCR mix was prepared as before except first round PCR product 
was used in place of the cDNA template, and the hemi-nested forward and reverse 
primers were added (Table 3.1). Thermal cycling conditions are as described above, 
except that 35 amplification cycles were used. Five µL of PCR product was analysed 
by 1.5 % agarose gel electrophoresis (120 V for 70 mins). Ljungan virus positive 
samples gave a band at approximately 373 bp after the first round PCR and 187 bp 
after the second round (Mantke et al., 2007).  
 
PCR product purification and DNA Sequencing 
Primers and unincorporated nucleotides were removed from PCR products using an 
ExoSAP digest. Five µl PCR product was added to 2 µl mix containing 10X RX 
buffer, 0.2 U Shrimp Alkaline phosphatase (USB, UK) and 1 U Exonuclease I (New 
England BioLabs, UK). Cycling parameters were 37 °C for 45 mins, 80 °C for 15 
mins. The cycle sequencing reaction was set up using the BigDye® Terminator v3.1 
Cycle Sequencing kit. One µl of ExoSAP product was added to a 9 µl reaction mix 
containing 5X sequencing buffer, 0.75 µl BigDye 3.1 (Applied Biosystems, Life 
Technologies, Paisley, UK) and 1.6 pM of LV forward or LV reverse primer. 
Cycling parameters were 25 three step cycles (96 °C for 10 sec, 50 °C for 5 sec, 60 
°C for 4 mins). The sequencing product was then precipitated using 3 M sodium 
acetate prior to resuspension in HiDi™ formamide (Applied Biosystems, Life 
Technologies, Paisley, UK), and then run on an ABI3130xl. 
 
PCR – 18S rRNA Housekeeping gene 
A housekeeping control was implemented to confirm successful reverse transcription 
of samples and so the presence of amplifiable DNA. cDNA from each sample was 
amplified in a separate PCR reaction using specific primers targeting the 18S 
ribosomal RNA; a gene present in all eukaryotic cells. Briefly, 1 µl of cDNA was 
PCR-amplified in a 14.5 µl reaction containing containing 75 mM Tris-HCl (pH 
8.8), 20 mM (NH4)2SO4, 0.01 % (v/v) Tween 20, 0.2 mM each dNTP, 1.5 mM 
MgCl2, 0.025 U Taq polymerase (ABgene), and 5 pM of the 18S rRNA primers and 
18S rRNA competimers (Ambion, UK). Cycling parameters were 95 °C for 10 mins, 
24 three step cycles (30 s at 94 °C, 30 s at 60 °C, 30 s at 72 °C) and 72 °C for 6 
mins. PCR product was analysed by 1.4 % agarose gel electrophoresis (120 V for 60 
mins). Evidence of amplifiable cDNA gave a band at approximately 489 bp.  
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3.4 Results 
PCR design and validation 
Many attempts were made to design superior primers targeting the 5‟UTR and VP1 
regions of the LV genome, as well as experimenting with different combinations of 
currently published primers to improve assays and provide better opportunity to 
detect UK LV strains. All were unsuccessful apart from a combination of primers 
from (Mantke et al., 2007) and (Nix et al., 2008), into a hemi-nested RT-PCR 
approach. 
  
Genome alignments confirmed the conservation of primer sites amongst the five 
published genomes and the two new strains described in Chapter 4 (Figure 3.1). 
Round one and two of the LV hemi-nested RT-PCR described here were both 
optimised for MgCl2 concentrations between 1.5 mM and 2.5 mM, annealing 
temperature ranging between 55 ̊C and 65 ̊C and cycle number ranging between 20 
and 40 increasing in five increments. Optimum conditions were 1.5 mM MgCl2 and 
60 °C for both rounds and to minimise non-specific binding, 20 cycles for round one 
and 35 cycles for round two. In comparison the published LV-specific real-time 
assay (Mantke et al., 2007) used 4 mM MgCl2, a single round of 40 cycles, and an 
annealing temperature of 60 °C. 
 
The optimised Ljungan assay was tested using positive Ljungan strains received 
from Bo Niklasson (AB Apodemus). Samples included four of the seven Ljungan 
virus strains (Johansson et al., 2002) (Chapter 4). The new assay was able to detect 
all of the Ljungan positive controls (Figure 3.2). When comparing the sensitivity of 
the standard assay minus the probe (Mantke et al., 2007) against our hemi-nested 
assay, we were able to show that our assay has a sensitivity 10-fold greater than that 
of the published method (Figure 3.3). Actual sensitivity limits were estimated using 
standards LV340 and LV342 (Chapter 4) with known viral copy numbers received 
from Bo Niklasson (AB Apodemus). Assuming RNA extraction and reverse 
transcription were 100 % efficient, this hemi-nested assay had a sensitivity threshold 
of at least 1x10
3
 viral copies. 
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Figure 3.1. Sequence alignments of the seven Ljungan virus 5‟UTR sequences and the published primers. Primers were obtained from (Mantke 
et al., 2007) (LVF and LVR) and (Nix et al., 2008) (AN344). The nucleotide sequences were retrieved from GenBank 
(http://blast.ncbi.nlm.nih.gov/) and were aligned in MEGA5 (Tamura et al., 2011). Ljungan virus accession numbers: LV87-012, AF327920; 
LV174F, AF327921; LV145SL, AF327922; LVM1146, AF538689; LV64-7855, EU854568. The numbering follows the LV87-012 sequence. 
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Figure 3.2. Ljungan virus validation panel tested using the hemi-nested RT-PCR 
assay, bands (187 bp) were observed on an agarose gel (1.5 %). 
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Figure 3.3. LV87-012 positive control dilution series run on an agarose gel (1.5 %) comparing second round band sizes using the a) standard 
Ljungan virus assay minus Taqman probe (Mantke et al., 2007), and b) the new optimised hemi-nested assay described here. 
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PCR quality assurance (QA) 
To validate the assay on actual rodent tissues, bank vole (M. glareolus) liver samples 
were provided in a quality assurance field panel (Bo Niklasson, AB Apodemus). 4/7 
positives and 5/5 negatives were in agreement however our hemi-nested assay failed 
to detect RNA in three positives previously detected using an unpublished LV 
specific real-time PCR used by the reference lab (AB Apodemus) (Table 3.2). Our 
results were also in accordance to the results obtained using the published LV real-
time PCR method minus Taqman probe (Mantke et al., 2007). 
 
 
Table 3.2. Comparison of LV diagnostic results of the field panel between the 
reference lab and the University of Liverpool. 
 
    Diagnostic result 
Sample UoL AB Apodemus 
152 Neg. Neg. 
153 Neg. Neg. 
154 Neg. Neg. 
155 Pos. Pos. 
160 Neg. Pos. 
161 Neg. Neg. 
162 Neg. Pos. 
163 Neg. Pos. 
170 Neg. Neg. 
171 Pos. Pos. 
172 Pos. Pos. 
173 Pos. Pos. 
Neg. = Negative, Pos. = Positive 
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An in vitro transcribed RNA sample (LV87-012) as published in (Mantke et al., 
2007) was provided by Bo Niklasson (AB Apodemus), however on testing, plasmid 
DNA was found to still be present. 
 
Screen results 
RNA from the livers of all animals sampled (n = 495) were negative for Ljungan 
viral RNA using this hemi-nested RT-PCR directed at the 5‟UTR. Given that we 
only caught a finite number of each rodent species and that none were found positive 
for LV RNA, from this data we cannot rule out prevalences less than approximately 
1.1 % for wood mice, 2.3 % for brown rats, 5.8 % for bank voles, 8.2 % for house 
mice and 32 % for field voles. The 18S housekeeping gene confirmed successful 
reverse transcription and the presence of amplifiable cDNA in all samples. The small 
cohort of fox livers were screened however the housekeeping gene failed suggesting 
the PCR was being inhibited, most likely as a consequence of the unclean nature of 
the liver and due to limited funds and time they could not be purified. 
 
A field vole (F174) trapped in Kielder forest previously believed to be infected with 
LV (97 % identical to LV87-012) (nucleotide sequence alignments created in 
Gblocks were provided by James Stewart, University of Liverpool) (Salisbury et al., 
2013) was also found positive for Ljungan viral RNA in this study, and on 
sequencing was 100 % identical to reference strain LV87-012. Exhaustive efforts 
were also made to replicate other positive results from tissue and RNA from 
Salisbury et al., 2013, however unfortunately they could not be repeated. A subset of 
liver samples was also sent to the reference laboratory in Sweden (AB Apodemus) 
for confirmation using the LV specific real-time assay (Mantke et al., 2007) and only 
one out of a previously suspected 12 reported by Salisbury et al., 2013 was positive 
for LV (unpublished data). 
 
3.5 Discussion 
Assay 
In this study we developed a new hemi-nested RT-PCR assay that combined primers 
from two published assays (Mantke et al., 2007; Nix et al., 2008). Only LV RNA 
from four isolates were available to test the specificity of the assay, representing 
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genotypes 1 and 2. Requests for the US strains (genotypes 3 and 4) were 
unsuccessful. However, sequence identity at the primer binding sites and 
confirmation from previous publications of the detection of all genotypes indicates 
there would be no issues in detecting the American strains also. This optimised 
hemi-nested assay detected all four strains available but also more importantly we 
were able to show a minimum 10-fold increase in the sensitivity (Figure 3.2 & 3.3) 
and crude estimations of the sensitivity limit using two standards with known viral 
copy numbers, LV340 and LV342 provided by Bo Niklasson found it to be at least 
1x10
3 
(1,000 viral copies).  
 
We were unable however to detect three positives in the field panel provided. Since 
this was the case with the LV real-time assay as well, it is thought that the likely 
cause of failure to detect RNA lies with the degradation of the panel rather than our 
assay. Regardless, to increase the sensitivity of our assay we first require sufficient 
sequence information specifically for indigenous UK strains. This can only be 
achieved by first performing a broad screen that ensures the best opportunity of 
detecting „all‟ LV variations; we are confident that the hemi-nested RT-PCR assay 
reported here will accomplish this. Once we have indigenous UK strain information, 
more sensitive methods can be designed.  
 
Screening 
Using this assay we were able to show that all animals collected for this study panel 
were negative for LV RNA. The only positive result we did find was from a field 
vole caught from a separate study in Kielder forest, Northumberland (Salisbury et 
al., 2013). Interestingly, this animal had also been found positive for LV RNA in a 
previous independent extraction although difference in sequence identity was 
observed. 
 
Data from this study suggests LV is not circulating in rodents around North West 
UK, particularly urban areas where our animals were primarily sourced from. Also it 
shows a large difference in the prevalence compared to the previous UK study 
(Salisbury et al., 2013) but perhaps this reflects the difference in habitat types, rural 
(Kielder forest) vs. urban (Liverpool). However we were able to confirm a single 
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positive animal from the previous study (Salisbury et al., 2013) and is suggestive 
that LV is in fact circulating elsewhere in the UK, perhaps in more rural areas. An 
explanation for finding no LV positive animals in urban environments could be that 
LV might not be maintainable in these fragmented urban rodent populations who 
potentially lack sufficient connectivity for the effective spread of the virus (Hess, 
1996; McCallum & Dobson, 2002). We might expect then to find positive animals 
just outside of these urban areas in the semi-rural environment, this was not the case. 
We did not find any LV infected animals in fresh rural rodent material collected for 
this study but perhaps the sample size was too small since rural rodents were not the 
primary target for this study.  If the virus was limited to rural areas it would most 
likely result in fewer human-rodent interactions and so the risk to humans would be 
lower.  
  
A possible explanation as to why we did not find any positive animals could be 
attributed to the testing approach. The screening process is reliant on the quality of 
diagnostic test and whilst we were able to show that our optimised assay has 
increased sensitivity over other published tests it does not necessarily mean that we 
will therefore detect all LVs. Firstly, it might be characteristic of LV to be present in 
very low copy numbers (Hauffe et al., 2010; Samsioe et al., 2009) (Niklasson 
unpublished data), perhaps sometimes even beyond that which our assay can detect. 
Secondly, UK LV could be quite distinct from American and Swedish isolates 
although the single sequence we obtained from a field vole suggests this was not the 
case. RNA viruses generally possess exceptionally high mutation rates (Domingo & 
Holland, 1997; Stanway, 1990), however they do show considerable nucleotide 
conservation in the 5‟UTR; PCR target region (Hyypiä et al., 1992; Stanway, 
1990)(data not shown). Thirdly, the Italian LV surveillance report suggested testing 
the liver for LV RNA (Hauffe et al., 2010), at the conception of this survey the 
reference lab (Niklasson pers. comms.) also advised that if an animal was positive 
for LV RNA it could always be detected in the liver; but not always in other tissues. 
However, the liver may in fact not be a primary target in LV pathogenesis. Previous 
studies have alluded to LV being possibly more neurotropic, targeting the brain and 
CNS (Mantke et al., 2007; Niklasson et al., 2009a) and greatest virus loads have 
previously been found in the brain of experimentally infected lab mice (Mantke et 
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al., 2007). Brain material has been archived from this survey however due to limited 
resources and advice from the reference lab it was not tested, perhaps in future it 
could also be screened for LV. If liver material is the optimal choice for LV 
detection, then there is still an issue of tissue tropism, in particular will LV be 
distributed throughout the tissue or be localised? Thus suggesting not all portions of 
a specific tissue might show a positive detection for LV RNA and so produce false 
negative results. Immunohistochemical staining of LV viral antigens have been 
observed in discrete areas of certain human tissues such as the chorionic plate of the 
placenta (Samsioe et al., 2009), beta cells of the pancreas (Niklasson et al., 2003a; 
Niklasson et al., 2003b) and the muscle fibres of the heart tissue (Niklasson et al., 
2009a; Tolf et al., 2008). These findings illustrate that LV might in fact be localised 
within tissues. In an attempt to minimise a potential effect of localisation within the 
liver, a 50-100 mg piece was homogenised and the whole homogenate was carried 
forward for RNA isolation. 
 
As was previously mentioned LV has been found in a number of rodent species, of 
these we only included four in this study, M. glareolus, M. agrestis, M. musculus and 
A. sylvaticus (Niklasson et al., 1999; Niklasson et al., 2006a; Salisbury et al., 2013). 
This study was largely focused on urban animals where the human zoonotic risk 
would be magnified, and so the two primarily rural rodent species, M. glareolus and 
M. agrestis were heavily under represented n = 50 and n = 8, respectively. Perhaps 
focus needs to be directed towards screening a larger number of these hosts, for 
confirmation. Whilst the brown rat has not previously been reported to have LV 
infection, it does not necessarily mean they cannot act as hosts, especially 
considering the current species range. 
 
This study has found no evidence of LV in rodents in the North West UK, however a 
sequence from a single positive field vole in Northumberland suggests this virus may 
be circulating elsewhere in the UK.   
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Chapter 4. Molecular characterisation of two new Ljungan virus isolates LV340 
and LV342 
 
4.1 Abstract 
Ljungan virus (LV) (family Picornaviridae, genus Parechovirus) is a suspected 
zoonosis with associations to human incidence of several disease in Sweden. LV is a 
single-stranded RNA virus with a positive sense genome. There are currently five 
published Ljungan virus strains, three Swedish and two American, and are classified 
into four genotypes. A further two strains described here were isolated from wild 
bank voles (Myodes glareolus) caught in Västmanlands county, Sweden in 1994. 
They were sequenced using next generation pyrosequencing technology on the 
GS454flx. Genetic and phylogenetic analysis of the obtained genomes confirm 
isolates LV340 and LV342 as two new members of genotype 2 along with 
LV145SL, with 92 % and 99 % identities respectively. Only two codon sites 
throughout the entire genome were identified as undergoing positive selection, both 
situated within the VP3 structural region, in or near to major antigenic sites. Whilst 
these two strains do not constitute new genotypes they have provided evidence 
suggesting the evolution of Ljungan virus to be markedly slow, a characteristic 
unlike other picornaviruses. Ultimately genomic information is required from 
different species as well as geographical locations to further understand the potential 
of this virus. 
 
4.2 Introduction 
Picornaviridae, a family of diverse viruses, are responsible for some common and 
serious diseases affecting humans and animals, examples being polio and foot-and-
mouth disease. According to the International Committee on Taxonomy of Viruses 
(ICTV), this family is currently divided into 17 confirmed genera: Aphthovirus, 
Avihepatovirus, Aquamavirus, Cardiovirus, Cosavirus, Dicipivirus, Enterovirus, 
Erbovirus, Hepatovirus, Kobuvirus, Megrivirus, Parechovirus, Salivirus, 
Sapelovirus, Senecavirus, Teschovirus and Tremovirus, although more have been 
proposed (Sauvage et al., 2012). The majority are comprised of pathogens of either 
humans or other animals however a few include both. Prior to 1998, the 
Parechovirus genus was thought to contain only human pathogens (Human 
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parechoviruses; HPeV) but several isolates of a novel rodent pathogen, Ljungan 
virus (LV) have since been discovered and proposed to be zoonotic (Niklasson et al., 
2003a; Niklasson et al., 2003b; Niklasson et al., 1999; Niklasson et al., 2006b; 
Samsioe et al., 2006; Samsioe et al., 2008) .  
 
Ljungan virus, originally isolated from bank voles (Myodes glareolus) in Sweden, 
has proposed associations with several diseases in humans including myocarditis, 
diabetes, Guillain-Barré syndrome (GBS) (Niklasson et al., 1998), intrauterine fetal 
death (IUFD) (Niklasson et al., 2007b), foetal malformations (Niklasson et al., 
2009b) and sudden infant death syndrome (SIDS) (Niklasson et al., 2009a). Whilst 
there is substantial evidence demonstrating the detection of both LV antigens and 
viral RNA in certain human disease cases, LV has not yet been confirmed as the 
cause (Niklasson et al., 2009a; Niklasson et al., 2003a; Niklasson et al., 1999; 
Niklasson et al., 2009b; Niklasson et al., 2007b). Very little is known as to the 
pathogenesis of LV but suggested target tissues in humans include the heart and 
brain, basically the areas where most research has so far been conducted (Niklasson 
et al., 2009a; Niklasson et al., 2009b). LV is thought to be transmitted via the faecal-
oral route, like other picornaviruses, with rodents as suggested sources (McDonald, 
2009). However, LV RNA has been detected in several rodent species and LV 
specific antigens have been detected in foxes, the full extent of carrier hosts is still 
unclear as the nature of infection is unknown (Hauffe et al., 2010; Johansson et al., 
2003; Johnson, 1965; Main et al., 1976; Niklasson et al., 2003a; Niklasson et al., 
1998; Niklasson et al., 2007a; Niklasson et al., 1999; Niklasson et al., 2006a; Tolf et 
al., 2009; Whitney et al., 1970).  
 
Parechoviruses are single stranded RNA viruses, with a positive sense genome 
approximately 7.5-8 kb long. The RNA genome contains one open reading frame 
that encodes a single polyprotein, human parechoviruses are made up of 10 
individual proteins and Ljungan virus has 11: VP0-VP3-VP1-(2A1-LV only)-2A2-
2B-2C-3A-3B-3C-3D (Chapter 1: Figure 1.3), each responsible for specific functions 
in virus replication and survival (Johansson et al., 2002; Racaniello, 2001). 
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Single stranded RNA viruses evolve exceptionally fast, mainly as a result of high 
mutation rates accrued because RNA polymerases lack any proofreading 
mechanisms, resulting in the accumulation of multiple mutations (Domingo & 
Holland, 1997; Holmes, 2003; Stanway, 1990). This provides a large „pool‟ of 
genetic diversity that under the right selective pressures is a strong driving force for 
virus evolution – quasispecies. Despite this increased error potential there remain 
areas of the genomes that have important roles in successful replication and are thus 
highly conserved, in particular those coding for non-structural proteins as 
presumably mutations in these regions would be costly for the virus‟ viability. The 
structural proteins in contrast are responsible for encoding the capsid proteins and 
tend to show a higher degree of variability mainly due to the immune pressure 
imposed by the host and the requirement to avoid recognition (Stanway, 1990).   
 
Currently there are five published LV genomes that cluster into four “genotypes” 
according to genetic and phylogenetic analysis: LV87-012 and LV174F (gt 1), 
LV145SL (gt 2) (Johansson et al., 2002), LVM1146 (gt 3) (Johansson et al., 2003) 
and LV64-7855 (gt 4) (Tolf et al., 2009). Genotypes 1 and 2 have been confirmed in 
bank voles in Europe whilst gt 3 and 4 have been found in two different vole species 
in America. LV has also been detected in wild rodents from Denmark, Italy and UK 
(Hauffe et al., 2010; Niklasson et al., 2007a; Salisbury et al., 2013). However there 
is no sequence information available for these. 
 
The more genetic information we can obtain for LV the closer we will be to 
understanding this virus. In this study we obtain a further two LV genome sequences 
from two recent isolates and assign them to genotype 2 using genome analysis. We 
review key motifs and structures within the available LV genomes. With access to 
more recent tools we analysed the evidence for positively selected sites on LV. 
 
4.3 Methods 
Virus strains  
Ljungan virus (LV) strains 340 and 342 were isolates extracted from wild caught 
bank voles (M. glareolus) in Västmanlands county, Sweden in 1994. They were 
grown in baby hamster kidney cells (BHK-21) for five passages before being passed 
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once through suckling mouse brain (SMB) in the reference laboratory in Sweden 
(AB Apodemus).  
 
RNA extraction, cDNA synthesis and PCR amplification 
Total RNA was extracted from whole brains using the QIAamp Viral RNA Mini Kit 
(Qiagen) following the manufacturer‟s standard protocol.   
 
RNA was reverse transcribed following a standard first strand cDNA synthesis 
protocol (Invitrogen Life Sciences, UK). Briefly, approximately 5 µg of RNA was 
reverse transcribed in a 20 µl reaction volume containing FR26RV-N (20 pmol) and 
FR40RV-T (1 pmol) primers (Djikeng et al., 2008), 10 mM dNTP mix (10 mM each 
dNTP), 5X First strand buffer, 0.1 M DTT and SuperScript™ III Reverse 
Transcriptase (200U) (Invitrogen Life Sciences, UK).  Cycling parameters were 65 
°C for 5 min, 25 °C for 5 min, 50 °C for 60 min and 70 °C for 15 min.   
 
cDNA was made double stranded by incubation with Exo-Klenow fragment (5U) 
(Ambion, UK); 5 µl first strand cDNA sample was added to a 25 µl reaction 
containing 100 pmol FR26RV-N (Djikeng et al., 2008) and 4 pmol 5‟ Ljungan virus 
specific primer (5‟-GCCGGAGCTCTGCAGATATCGGTGGGGTGG-3‟), 500 mM 
Tris-HCl, 10 mM dNTP mix, 50 mM MgCl2, 0.1 M DTT and 5 mg/ml
 
BSA. The 
reaction was heated to 95 °C for 5 min and then maintained at 37 °C for 30 min, 1 µl 
of 0.5 M EDTA was added to stop the reaction.  Primers were removed from the 
double stranded cDNA by incubating the reaction at 37 °C for 30 mins with shrimp 
alkaline phosphatase (ds cDNA, 0.2U Shrimp Alkaline Phosphatase (SAP) (USB, 
UK) and 1U Exonuclease I (New England BioLabs, UK).   
 
The double stranded cDNA was then PCR-amplified using the Advantage 2 
Polymerase protocol (Clontech, UK). Briefly, cDNA was amplified in a 50 µl final 
reaction volume containing 10X Advantage buffer, FR20V primer (10 pmol), 10 
mM dNTP mix and 50X Advantage® 2 Polymerase mix (Clontech, UK). Thermal 
cycling parameters were 95 °C for 1 min, 15 two step cycles (30 s at 95 °C, 6 min at 
68 °C) and at 68 °C for 6 minutes.   
454 sequencing  
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Library construction and pyrosequencing was completed by the Centre for Genomic 
Research (CGR, http://www.liv.ac.uk/cgr/), University of Liverpool, UK on a 454 
GS FLX system (Roche). Samples LV340 and LV342 were multiplex identified 
(MID-tagged) and sequenced using 1/16 GS454flx sequencing run. Viral genome 
sequencing was thus random with regard to the total RNA present. Sequencing reads 
were quality trimmed and adaptor and primer sequences were removed prior to 
assembly. Contig assembly was performed using Newbler (release 1.1.03.24.Roche) 
with overlap settings of 35 bp and 99 % identity and default value for the remaining 
parameters. 
 
BLAST identity searches and sequence annotation 
Sequence contigs were submitted to BLAST for identification. Briefly, contigs were 
compared against the Ljungan virus viral protein Uniprot database (accessed 
5/2/2010) with an e-value cut off of 1e
-5 
(probability of the alignment occurring by 
chance), identity searches were conducted using BLASTX implemented in the 
standalone blast program (Altschul et al., 1990). Apparent gaps in the Ljungan virus 
genomes were filled by designing primers that flanked the gap and then subsequent 
PCR and Sanger sequencing. 
 
Phylogenetic trees 
Representative 3D
pol
 and VP1 sequences for members of the picornavirus family 
were taken from UniProt (Consortium, 2012) and used for phylogenetic analysis 
(Table 4.1). Multiple amino acid sequence alignments were generated in MEGA5 
(Tamura et al., 2011). Sequence identities were compared using Geneious 5.6.5 
(Biomatters: www.geneious.com, date accessed: 1/8/12). Maximum likelihood 
phylogenetic trees were produced in MEGA5 (Tamura et al., 2011) with bootstrap 
replications of 1,000 (Felsenstein, 1985). Optimum substitution models were 
estimated in MEGA5 (Tamura et al., 2011).  
 
Positive selection 
Sites specific positive selection (adaptive evolution) was identified by calculating the 
ratio of dN (Non-synonymous)-to-dS (Synonymous) substitutions. The analysis was 
performed using the Datamonkey HYPHY package web interface 
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(http://www.datamonkey.org/) (Delport et al., 2010; Pond & Frost, 2005a; Pond et 
al., 2005). All 11 viral genes were analysed separately for the seven genomes. 
Random effects likelihood (REL), fixed effects likelihood (FEL) and single 
likelihood ancestor counting (SLAC) (Pond & Frost, 2005b) were employed to 
predict putative selection. Sites were considered under positive selection if 
significant support was found in two or more methods (SLAC/FEL: p<0.1; and REL: 
Bayes factor >100).  
 
Recombination 
Recombination events were analysed using the GARD and SBP models 
(http://www.datamonkey.org/) (Pond et al., 2006). 
 
RNA secondary model prediction 
The predicted RNA secondary folding structure was modeled using the mfold 
software version 3.5 (http://mfold.rna.albany.edu/?q=mfold) (Zuker, 2003). 
 
4.4 Results and Discussion 
Sequence output and assembly statistics 
Sequencing of LV340 sample yielded a total of 1,149 contigs (totaling 369,911 bp) 
and 53,047 singletons, with a mean length of 322 bp (ranging between 97-3841 bp) 
and an average read depth of 7. There were 53 contigs ≥500 bp. For sample LV342 
sequencing yielded a total of 3,216 contigs (totaling 1,148,716 bp) and 73,030 
singletons, with a mean length of 357 bp (93-4535 bp) and an average read depth of 
4. There were 90 contigs ≥500 bp.  
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             Table 4.1. Picornavirus representatives used in the 3D
pol 
and VP1
 
analysis. 
 
Genus Virus/ Strain Abbreviations Uniprot no. 
Aphthovirus Foot-and-mouth disease virus (strain O1) FMDV1 P03305 
 Foot-and-mouth disease virus (strain C1-SantaPau) FMDV2 P03311 
Aquamavirus Seal picornavirus type 1 SePV1 A8D7N3 
Avihepatovirus Duck hepatitis A virus DHV1 Q0GH72 
Cardiovirus Encephalomyocarditis virus EMCV P03304 
 Mengo encephalomyocarditis virus MENGO P12296 
 Saffold virus SAFV A4ZKN2 
 Theiler's murine encephalomyelitis virus (strain GDVII) TMEV P08545 
Cosavius Human cosavirus A1 HCoSV B8XTP8 
Dicipivirus Canine picodicistrovirus CPDV H6VBU5 
Enterovirus Bovine enterovirus (strainVG-5-27) BEV P12915 
 Coxsackievirus B3 (strain Nancy) CAB P03313 
 Human enterovirus 70 (strain J670/71) HEV P32537 
 Human rhinovirus 2 HRV2 P04936 
 Poliovirus type (strain Sabin) PV P03301 
 Swine vesicular disease virus (strain UKG/27/72) SVDVU P13900 
Erbovirus Equine rhinitis B virus 1 (strain Equine/Switzerland/P1436/71/1971)  ERV Q66776 
Hepatovirus Human hepatitis A virus genotype IA (isolate LA) HAV1 P06441 
 Human hepatitis A virus genotype IB (isolate MBB) HAV2 P08617 
Kobuvirus Aichi virus AIV O91464 
    
6
8
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Table 4.1. continued. 
 
 
  
    
Genus Virus/ Strain Abbreviations Uniprot no. 
Megrivirus Turkey hepatitis virus THV E9L812 
Parechovirus Ljungan virus 87-012 LV87012 Q8JV21
 
 Ljungan virus 174F LV174F Q8JV20
 
 Ljungan virus 145SL LV145SL Q8JV19
 
 Ljungan virus M1146 LVM1146 Q80N16
 
 Ljungan virus 64-7855 LV647855 C0J6D4 
 Human parechovirus 1 (Harris) HPeV1 Q66578
 
 Human parechovirus 2 (Williamson) HPeV2 O73556 
 Human parechovirus 3 HPeV3 G1UJH6 
 Human parechovirus 4 HPeV4 Q00MX7 
 Human parechovirus 6 HPeV6 A7LIU8 
 Human parechovirus 7 HPeV7 B9UD49 
 Human parechovirus 8 HPeV8 B9UK62 
 Human parechovirus 11 HPeV11 ADV16096 
Salivirus Salivirus NG-J1 SVNGJ1 C5MSH2 
Sapelovirus Porcine sapelovirus (strain V13) PSV13 O91257 
Senecavirus Seneca Valley virus (isolate United States/SVV-001/2002) SVV Q155Z9 
Teschovirus Porcine teschovirus 1 (isolate Pig/United Kingdom/F65/1967) PTV Q9WJ28 
Tremovirus Avian encephalomyelitis virus (strain Calnekvaccine) AEV Q9YLS4 
Pasivirus
a
 Swine pasivirus 1 SPaV1 I6YQK4 
Picorna-related insect virus Infectious flacherie virus IFV O70710 
 Sacbrood virus SBV Q9WCE9 
a
Proposed genus (Sauvage et al., 2012)   
8
0
 
6
9
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Based on BLASTX identity searches against a Uniprot Ljungan virus database, we 
identified four LV specific contigs (0.35 %), contig31 (3,840 bp), contig57 (3,027 
bp), contig208 (477 bp), and contig977 (123 bp) for sample LV340 and three gaps of 
approximately 118, 40 and 86 bp. For sample LV342 two LV specific contigs were 
identified (0.06 %), contig14 (2,571 bp) and contig237 (3,724 bp) with three gaps of 
approximately 143, 98 and 1048 bp. Gaps were filled as described in the methods. 
 
Identity 
Alignment of protein sequences of the LV340 and LV342 isolates with the five 
published LV genome sequences and a closely related Human parechovirus (HPeV1-
Harris prototype serotype) shows clear similarity between our isolates and the 
Swedish LV145SL genotype, with at least 96.6 % identity across the whole genome 
(Table 4.2). It is easiest to observe conserved proteins across all LVs by scanning the 
more distantly related strains from America e.g. LVM1146 and LV64-7855, since all 
Swedish strains are relatively similar making it difficult to distinguish overall 
patterns. Whilst the non-structural proteins (2A1-2A2-2B-2C-3A-3B-3C-3D) share 
between 75.0-93.6 % aa sequence identity, structural proteins (VP0-VP3-VP1) 
exhibit greater variability 70.1-78.3 % aa,. Interestingly, the LV340 and LV342 
membrane associated proteins 2B, 2C
ATPase
 and 3A, whilst these regions are similar 
to the genotype 2 (LV145SL), show a higher degree of identity with the American 
genotypes rather than the other Swedish genotype. This is particularly interesting as 
these isolates are geographically isolated, and as such provide evidence of a cross 
over event or questions the virus‟ origin. 
 
Both isolates also exhibit single nucleotide polymorphisms (SNPs) that are different 
to their consensus genome sequences. LV340 had three SNPs all located within the 
structural proteins: G740A (VP0), T2152C (VP3) and A2801G (VP1), and two of 
these resulted in non-synonymous changes G740A (Valine to Isoleucine) and 
A2801G (Lysine to Glutamate). LV342 also had three SNPs, however two were 
located in the non-structural proteins: T2145C (VP3), G3455A (2A2) and T4014C 
(2C). G3455A was the only non-synonymous mutation (Glutamate to Glycine). 
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Genome analysis 
The individual protein cleavage sites previously predicted for Ljungan virus 
genomes (Johansson et al., 2003; Johansson et al., 2002) are consistently found in 
these two isolates providing further support for these sites. 
 
5’UTR 
It has been reported that the 5‟UTR shows considerable similarity amongst closely 
related viruses (Stanway, 1990). This is presumably due to the specific function that 
it facilitates in RNA replication (Ekström et al., 2007; Tolf et al., 2009). Sequence 
identity comparisons between LV340, LV342, published LVs and HPeV 5‟UTR 
nucleotide sequences are displayed in Table 3. Several studies have looked at the 
precise secondary folding of this region and found that it encodes for an internal 
ribosome entry site (IRES), a structure vital for cap-independent initiation of 
translation (Belsham, 2009; Racaniello, 2001). This IRES, previously predicted in 
published Swedish and American Ljungan viruses (Johansson et al., 2002; Tolf et 
al., 2009) can now also been found within these two sequences in this study, 
exhibiting high similarity, in particular in the two motifs reported to be important for 
functionality, a GNRA and a pyrimidine rich region (Johansson et al., 2003). The 
specific folding corresponds to a type II IRES, and is the most common amongst 
members of the picornaviridae including closely related parecho- and cardioviruses 
(Ghazi et al., 1998; Racaniello, 2001). The IRES which is situated at the 3‟ end of 
the 5‟UTR lies short of an initiator codon, a motif located in an optimal Kozak 
context ANNAUGG (Hyypiä et al., 1992; Johansson et al., 2002; Kozak, 1986) and 
indicates the beginning of the coding polypeptide. From our analysis our two 
genomes conform to the predicted initiation codons for all published LV genotypes. 
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Table 4.2. Comparison of the percentage protein identities between the two new Ljungan isolates, LV340 (non-bold) and 
LV342 (bold) with all LV strains and HPeV1-Harris prototype. 
 
 
 
 
 
 
 
 
 
 
 
 
                     Table 4.3. Nucleotide comparison of three important genomic regions in LV340 (non-bold) and LV342 (bold). 
 
 
 
 
 Genotype 1 Genotype 2 Genotype 3 Genotype 4 HPeV1 
(Harris) Region LV87-012 LV174F LV145SL LVM1146 LV64-7855 
       
VP0 90.0   90.0 90.0   90.0 99.2   99.6 74.5   74.9 76.4   76.4 42.9   43.2 
VP3 84.4   84.4 84.4   84.4 99.6   99.6 74.2   74.6 77.9   78.3 54.6   54.6 
VP1 79.1   78.8 79.5   79.1 98.0   99.3 70.0   70.0 72.1   72.1 37.5   36.6 
2A1 85.0   85.0 85.0   85.0 100.0   100.0 90.0   90.0 75.0   75.0 NA 
2A2 94.8   94.8 94.8   94.8 98.5   99.3 84.4   82.2 85.9   85.2 44.2   42.8 
2B 89.3   89.3 90.0   90.0 100.0   100.0 92.9   92.9 93.6   93.6 52.0   52.0 
2C 80.8   80.8 80.8   80.8 99.4    100.0 88.0   87.4 89.2   88.6 51.7   51.4 
3A 77.7   77.7 77.7   77.7 100.0   100.0 80.0   80.0 80.8   80.8 30.5   30.5 
3B 89.7   89.7 89.7   89.7 96.6   96.6 79.3   79.3 89.7   89.7 31.0   31.0 
3C 98.0   98.0 97.0   97.0 100.0   100.0 87.4   87.4 86.4   86.4 48.0   48.0 
3D 97.0   97.9 96.4   97.0 98.7   99.6 83.4   83.4 84.3   83.8 48.9   49.1 
 
Region LV87-012 LV174F  LV145SL LVM1146 LV64-7855 HPeV1 (Harris) 
       
5‟UTR 85.0   85.2 86.1   85.8 94.8   99.9 68.0   66.6 71.6   72.4 46.0   44.9 
3‟UTR 87.7   90.4 86.8   88.6 92.7   99.1 61.0   61.9 65.7   65.7 42.4   45.7 
VP1 72.8   71.7 71.8   70.9 89.8   99.8 64.4   65.2 67.2   67.3 47.3   48.3 
       
7
2
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Polyprotein 
Key features of the polyprotein previously identified in reference Ljungan virus 
genomes and other parechoviruses (Ghazi et al., 1998; Hyypiä et al., 1992; Oberste 
et al., 1998) are also conserved in the two genomes presented here. These include the 
BC loops and β-barrels (Johansson et al., 2003; Racaniello, 2001; Rossmann & 
Johnson, 1989; Tolf et al., 2009) that make up the conserved eight-stranded 
antiparallel beta-barrel structure found across picornaviruses (Niklasson et al., 1999) 
and hold the major neutralizing antigenic sites, structures involved in immune 
selection (Mateu, 1995; Racaniello, 2001). The 2A1 DvExNPgIP motif found in 
several picornaviruses and suggested to be involved in promoting the separation of 
the 2A│2B proteins (Johansson et al., 2003). The 2CATPase involved in RNA 
synthesis (Gorbalenya & Koonin, 1993). The 3B protein which is highly conserved 
amongst LVs and responsible for encoding a viral VPg peptide, essential for 
successful polymerase activity (Johansson et al., 2002; Paul et al., 1998; Racaniello, 
2001; Tolf et al., 2009). In addition, the 3B is also the site of the cre (cis-acting 
replication element); a structure found in many picornaviruses (Goodfellow et al., 
2000), and is important in the initiation of virus replication by the uridylation of the 
VPg peptide (Paul et al., 2000; Rieder et al., 2000; Tolf et al., 2009). 3C
pro
 involved 
in the processing of the individual proteins at the inter domain junctions (Johansson 
et al., 2002). 
 
3-UTR 
The 3‟UTR region is important in the replication and translation of the picornavirus 
genome (Dobrikova et al., 2003; Rohll et al., 1995), although its definitive function 
is still unknown. A comparison of the predicted secondary folding of the 3‟UTR 
regions of LV340 and LV342 show a similar stable folding structure to LV87-012 
(Figure 4.1a) (Johansson et al., 2003), however energy optimal folds are lower for 
LV340 and LV342 with ΔG = -19.60 and -23.30 Kcal mol-1, respectively. This 
suggests the stem loop structure of these new isolates are less stable than all the 
Swedish genotypes LV87-012, LV174F and LV145SL but less open and more stable 
than the American genotypes (LVM1146: ΔG = -17.8 Kcal mol-1 and LV647855: ΔG = -
17.2 Kcal mol
-1
) (Figure 4.1a - g) (Johansson et al., 2003). Domain II of the 3‟UTR 
folding structure is highly conserved amongst LV and remains to be the case with the 
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addition of these two new genomes therefore suggesting their significant role in viral 
replication. 
 
Classification 
Whilst the exact criteria for classifying new LV strains is undetermined, a method 
employed for enteroviruses and that is supported by the current genotype placings, is 
that a new isolate is considered to be homologous to current genotypes providing 
that nucleotide and amino acid sequence identities of the VP1 region are >75 and 
>88 %, respectively (Oberste et al., 1999; Tolf et al., 2009). If we apply these 
criteria to LV340 and LV342 then they clearly join LV145SL as two new members 
of genotype 2 (Table 4.2 & 4.3). The addition of these genomes further supports the 
inclusion of LV within the parechovirus genus. 
 
Phylogenetic tree 
Further support for LV placing can be deemed from phylogenetic analysis. LV has 
been proposed to be situated with the parechoviruses yet still be sufficiently different 
to be potentially classed as a separate genus (Johansson et al., 2002; Lindberg & 
Johansson, 2002; Tolf et al., 2009). With the addition of the two new isolates, 
phylogenetic analysis of the 3D
pol 
region confirms the classification of LV as a 
species within the parechovirus genus (Figure 4.2a). Phylogenetic analysis of the 
VP1 protein (Oberste et al., 1999) further supports the presence of LV and human 
parechoviruses as two distinct species within the genus (Figure 4.2b).  
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Figure 4.1. Predicted secondary structures from mfold version 3.5 for the 3‟UTR of 
LV87-012: ΔG = -30.4 Kcal mol-1 a), LV174F: ΔG = -26.9 Kcal mol-1 b), LV145SL: ΔG = -
26.9 Kcal mol
-1
 c)
, LV340: ΔG = -19.6 Kcal mol-1 d), LV342: ΔG = -23.3 Kcal mol-1 e), 
LVM1146: ΔG = -17.8 Kcal mol-1 f), and LV64-7855: ΔG = -17.2 Kcal mol-1 g) (Johansson et 
al., 2003). 
 
 
d) 
a) 
b) 
c) 
Domain I Domain II 
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Figure 4.1. continued.  
 
 
 
f) 
e) 
g) 
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Figure 4.2. Maximum likelihood trees using the models rtREV+G (Dimmic et al., 
2002) for 3D
pol
 sequences n = 38 (a) and  WAG+G (continued overleaf). 
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Figure 4.2 continued.  (Whelan & Goldman, 2001) for VP1 sequences n = 15 (b) in 
MEGA5 (Tamura et al., 2011). The trees are drawn to scale, with branch lengths 
measured in the number of substitutions per site. The scale bar indicates amino acid 
substitutions per site. Only bootstrap support of >70 % are shown. Positions with 
less than 95 % site coverage were eliminated. There were a total of 239 positions for 
the 3D
pol
 and 211 for the VP1 in the final datasets. The phylogenetic positions of 
LV340 and LV342 are shown in relation to representative picornaviruses a) and 
more closely related parechoviruses b). Uniprot accession numbers as shown in 
Table 4.1 
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Positive selection 
Many picornaviruses have been reported to undergo positive selection including the 
closely related human parechoviruses (Benschop et al., 2008; Fares et al., 2001; 
Faria et al., 2009; Simmonds, 2006). In each case immune-mediated selection is 
proposed to be acting on the structural proteins of the virus. When investigating 
selection amongst the seven LV genomes it was found that most regions were 
predominantly evolving neutrally with a good proportion also showing signs of 
being under purifying selection. There were however two sites in the VP3 protein 
that were being positively selected for, codons 96 and 197 (Table 4.4), suggesting 
mutations at these sites are being fixed due to an inferred biological advantage. Site 
96 is located in the predicted BC-loop of the VP3 capsid protein, a major antigenic 
site in picornaviruses, a site implicated in the virus-immune system interaction and 
shown to be involved in the viruses evasion from neutralization by monoclonal 
antibodies (Mateu, 1995; Niklasson et al., 1999). Site 197 is located within the 
suggested beta strand G2 of the VP3 beta-barrel complex (Niklasson et al., 1999; 
Stanway et al., 1994). Throughout the whole coding region there was a considerable 
amount of sites evolving neutrally, coupling this with the limited positive selection 
observed and the fact that the two American genotypes were isolated between 1962-
1965 implies these geographically isolated viruses are not evolving very fast, a 
characteristic unusual for RNA viruses. Picornaviruses are typically found to have 
extremely large mutation rates of almost one mutation per replication, close to the 
viability threshold (Agol, 2002; Drake & Holland, 1999). The „slow‟ evolution may 
suggest that LV could potentially be „avoiding‟ immune pressure in some other way. 
Human parechoviruses, the other species within the genus exhibit high substitution 
rates (Faria et al., 2009), although these are reported to be solely human pathogens 
and as a result may not be directly comparable to Ljungan virus. When broadening 
the category to include RNA viruses found in a variety of mammal hosts, typical 
substitution rates have been reported within the range of 10
-2
 – 10-4 nucleotide 
substitutions per site per year (Hanada et al., 2004; Jenkins et al., 2002). Variations 
in these substitution rates could be attributed to differences in the infection e.g. long-
term (chronic) infections may prevent the necessity to evolve fast, and the mode of 
transmission, for example multi-host viruses will require increased substitution rates 
to successfully transmit (Hanada et al., 2004). Further evolutionary analysis is 
required to determine the substitution rate for LV. 
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Table 4.4. Identified positively selected sites within the VP3 protein.  
  FEL
a 
REL
b 
Region Codon dN-dS p value dN/dS Bayes factor 
VP3 96 0.92
 
0.05    0.64 170.62 
VP3 197 0.75 0.06 0.86 331.74 
 
 
a
 p < 0.1  
 
b
 Bayes factor > 100  
 
 
A factor that needs to be taken into consideration is the potential of recombination 
within the genomes as this could result in false positives (Pond et al., 2006) when 
looking for sites under selection. We already know that the LV genome has a 
recombination point in the 2C3A region (Tolf et al., 2009), however on testing the 
VP3 region no breakpoints were found with significant support to suggest a 
recombination event that could explain the selection seen and there is also support 
from the congruence of tree topologies (data not shown). Recombination analysis 
throughout the genome found only one site with significant support to suggest a 
recombination event located within the 3A protein. This would suggest the positive 
selection observed in the VP3 region is genuine and not an artifact of recombination. 
 
Conclusion 
As expected LV340 and LV342 exhibit greater sequence divergence in the structural 
rather than non-structural regions, this is most likely due to the immune pressure 
imposed on the virus to avoid recognition. A surprisingly large amount of neutral 
selection was observed across the LV genomes, with positive selection only being 
seen at two codons within the VP3 gene, one of which is located in a suggested 
antigenic site. These two isolates contain all the key motifs and structures of the five 
previously published isolates of Ljungan virus. Phylogenetic analysis confirms the 
placing of LV amongst the picornaviruses and within the parechovirus genus. All 
evidence supports the inclusion of LV340 and LV342 not only within the Ljungan 
virus clade but more specifically within genotype 2 alongside LV145SL. The more 
sequence information we can collect for LV especially from different locations, the 
better we are in understanding it, and should it be confirmed as a zoonosis then this 
information will inevitably benefit future research. All researchers publishing LV 
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prevalence data should be obliged to publish their sequence data to expand the 
understanding of LV epidemiology in different hosts and countries. 
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Chapter 5. Hantavirus surveillance in the United Kingdom 
Adapted from Pounder et al. (2013) Emerging Infectious Diseases 19: 673-675 
(Appendix 3) 
 
5.1 Abstract 
Serological studies and sporadic human cases have previously suggested the 
presence of hantavirus in the UK.  However, until recently the species of hantavirus 
present in UK wildlife has never been confirmed.  Between September 2009 and 
November 2011, wild rodents consisting of brown rats (Rattus norvegicus), wood 
mice (Apodemus sylvaticus), house mice (Mus musculus), bank voles (Myodes 
glareolus) and field voles (Microtus agrestis) were live caught across North West 
England (Cheshire, Liverpool and Wirral). With the exception of a single field vole, 
the lungs from all rodents sampled were negative for hantaviral RNA using a pan-
hantavirus RT-PCR. However, partial sequences for small (S) and large (L) genome 
segments were recovered from the lung of the field vole and confirmed the presence 
of a novel hantavirus (Tatenale Virus) in the United Kingdom. Coincidently in 2012, 
HPA investigations following a case of haemorrhagic fever with renal syndrome in 
Northern England, led to the subsequent isolation of Seoul hantavirus from a wild 
brown rat.  The prevalence and public health impact of the two hantavirus species in 
the UK are not yet known. 
 
5.2 Introduction 
Hantaviruses are single-stranded RNA viruses that form their own distinct genus 
within the Bunyaviridae. Unlike other members of the Bunyaviridae, hantaviruses 
are not transmitted by arthropods but primarily by rodents of the families Cricetidae 
and Muridae, although insectivore and bat hosts have recently been reported 
(Klempa et al., 2007; Weiss et al., 2012). Each hantavirus appears to be adapted and 
largely restricted to an individual reservoir host species, implying that they have co-
evolved, although phylogenetic analyses suggest that this apparent co-evolution may 
be more attributed to recent preferential host switching and local adaptation 
(Ramsden et al., 2009). 
 
Transmission to humans is primarily via inhalation of aerosolised virus in 
contaminated rodent urine and faeces. Whilst infected reservoir hosts are 
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asymptomatic, human infections can lead to two clinical manifestations, 
haemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary 
syndrome (HCPS), with varying degrees of morbidity, mortality and burden (Vaheri 
et al., 2012). 
 
Zoonotic surveillance projects throughout Europe have detected five rodent-borne 
hantaviruses; Dobrava-Belgrade (DOBV), Saaremaa (SAAV), Seoul (SEOV), 
Puumala (PUUV) and Tula (TULV) plus two insectivore-borne hantaviruses; Seewis 
(SWSV) and Nova (NVAV) (Olsson et al., 2010; Vaheri et al., 2012). The relative 
geographic distribution of each hantavirus is defined by their reservoir host (Olsson 
et al., 2010). All mainland European countries neighbouring the UK have reported 
hantavirus infections. The most common and widespread hantavirus across northern, 
central and eastern Europe is PUUV, which is associated with the mildest form of 
HFRS (Vaheri et al., 2012). 
 
There have been very few human hantavirus cases reported in the UK and in all 
instances the causative virus species was not confirmed in clinical specimens 
(reviewed in (Fhogartaigh et al., 2011; McCaughey & Hart, 2000) (Table 1.1: 
Chapter 1). If these were all caused by the same hantaviral agent then there does not 
appear to be a consistent clinical picture for HFRS in the UK and do not match 
entirely to the guidelines outlined by WHO (Gajdusek et al., 1983). In several cases 
it was noted that rodent exposure coincided with the onset of symptoms whilst no 
patients had been abroad, suggesting the acquisition of a strain circulating in the UK. 
Further evidence of hantaviruses circulating naturally in the UK comes from 
longitudinal studies which reported considerable hantavirus seropositivity in human 
cohorts. The majority of these studies included healthy individuals suggesting past 
exposure to hantaviruses or subclinical infection (seroprevalence 1-4.8 %) (Coleman, 
2000; Davies et al., 1988; McCaughey & Hart, 2000; McKenna et al., 1994; Pether 
& Lloyd, 1993; Stanford et al., 1990; Thomas et al., 1999). In addition, serological 
surveys of rodents (rats and mice) and cats in the UK have reported the presence of 
hantavirus specific antibodies but not the species of hantavirus (Bennett et al., 1990; 
Davies et al., 1988; Lloyd, 1991; McCaughey & Hart, 2000; McCaughey et al., 
1996; Pether & Lloyd, 1993; Stanford et al., 1990; Webster & Macdonald, 1995).  
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It was only in the later stages of 2012 that the first confirmation of SEOV RNA was 
found in UK brown rats (R. norvegicus) (Jameson et al., 2013a). A patient from the 
Humber region with suspected hantavirus disease was confirmed to have high 
hantavirus antibodies to HNTV and SEOV, and this led to the subsequent trapping of 
rodents at their residence. Two of four brown rats tested were found positive for 
hantavirus RNA, this indigenous UK SEOV has been designated strain Humber 
(Jameson et al., 2013a). There are several ports situated along the Humber estuary 
that could have facilitated the introduction of SEOV infected rats into the UK, 
interestingly however genetic analysis of this strain confirm it to be most similar to 
IR461, a strain that was previously responsible for UK human laboratory-acquired 
infections (Jameson et al., 2013a; Shi et al., 2003). Further work is required to 
confirm the Humber strains pathogenicity to humans. 
 
At the commencement of this project there had been no confirmation of hantaviruses 
circulating in the UK, however since then Seoul virus RNA has been found in the 
brown rat (Jameson et al., 2013a). Questions that remain to be answered are whether 
SEOV can be found in rats throughout the UK and is this the only hantavirus species 
circulating? This study aimed to determine, using a molecular approach, if 
hantaviruses are circulating in rodents in the North West UK. It is hypothesised that 
we would find Seoul virus due to the ubiquitous presence of its host the brown rat 
and the North West‟s strong links with sea travel that has facilitated rat distributions 
and with it possibly the introduction of Seoul virus. To test this we screened five 
rodent species using a published Pan-hantavirus PCR assay (Klempa et al., 2006). 
 
5.3 Methods 
Field work  
Rodents (n = 495) consisting of brown rats (R. norvegicus) (n = 133), wood mice 
(Apodemus sylvaticus) (n = 269), bank voles (Myodes glareolus) (n = 50), house 
mice (Mus musculus) (n = 35) and field voles (Microtus agrestis) (n = 8) were live 
caught across North West England (particularly in and around Liverpool, Chester 
and Wirral, see Chapter 2). Animals were sacrificed in the field by inhalation of 
Isoflurane, following UK Home Office Guidelines. Where possible, kidney, liver and 
lung tissues, were removed within 1 hour of euthanasia. Blood samples were 
collected when field conditions allowed, otherwise heart tissue was retained. The 
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samples, and if necessary the unprocessed carcases, were stored at -80 °C until 
required. 
 
RNA extraction and reverse transcription 
50-100 mg of tissue was homogenised in 1 ml TRIzol® Reagent (Invitrogen, Life 
Technologies, Paisley, UK) with QIAGEN Stainless steel beads (5 mm) using a 
QIAGEN TissueLyser (Qiagen, UK) for 2 mins at 30 Hz. RNA was extracted from 
the homogenate as described in the Invitrogen TRIzol® Reagent instructions for 
animal tissues (Invitrogen, Life Technologies, Paisley, UK). RNA was purified using 
Ambion® PureLink™ RNA Mini Kit (Life Technologies, Invitrogen, Paisley, UK) 
and quantified using the Qubit® Fluorometer (Invitrogen, Life Technologies, 
Paisley, UK), as described in the manufacturer‟s protocol, and stored at -80 °C until 
reverse transcription. 
 
RNA was reverse transcribed following a standard first strand cDNA synthesis 
protocol (Invitrogen, Life Technologies, Paisley, UK). Briefly, RNA (>1 µg) was 
reverse transcribed in a 20 µl reaction containing 50 ng/µl random hexamers, 10 mM 
dNTP mix (10 mM each of dATP, dGTP, dCTP and dTTP at neutral pH), 5X First 
strand buffer, 0.1 M DTT and 200 U SuperScript™ III Reverse Transcriptase 
(Invitrogen, Life Technologies, Paisley, UK). Cycling parameters were 65 °C for 5 
mins, 50 °C for 60 mins and 70 °C for 15 mins in a Techne TC-5000 Thermal 
Cycler. The cDNA was stored at -20 °C. 
 
Pan-hantavirus RT-PCR 
Two µl of cDNA was PCR-amplified in a 14.5 µl reaction containing 75 mM Tris-
HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01 % (v/v) Tween 20, 0.2 mM each dNTP, 1.5 
mM MgCl2, 0.025 U Taq polymerase (ABgene) and 10 pM (each) of the first round 
forward and reverse primers (Eurofins MWG Operon, Germany) (Klempa et al., 
2006). Cycling parameters were 95 °C for 15 mins, 40 three step cycles (30 s at 95 
°C, 45 s at 53 °C, 30 s at 72 °C) and 72 °C for 6 mins. 
 
The second round PCR mix was made up as before except first round PCR product 
was used in place of the cDNA template, and the nested forward and reverse primers 
were added. Thermal cycling conditions are as described above. Five µL of PCR 
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product were analysed by 1.5 % agarose gel electrophoresis (120 V for 70 mins). 
Hantavirus positive samples gave a band at approximately 452 bp after the first 
round and 390 bp after the second round (Klempa et al., 2006). 
 
PCR product purification and DNA Sequencing 
Primers and unincorporated nucleotides were removed from PCR products using an 
ExoSAP digest. Five µl PCR product was added to 2 µl mix containing 10X RX 
buffer, 0.2 U Shrimp Alkaline phosphatase (USB, UK) and 1 U Exonuclease I (New 
England BioLabs, UK). Cycling parameters were 37 °C for 45 mins, 80 °C for 15 
mins. The cycle sequencing reaction was set up using the BigDye® Terminator v3.1 
Cycle Sequencing kit. One µl of ExoSAP product was added to a 9 µl reaction mix 
containing 5X sequencing buffer, 0.75 µl BigDye 3.1 (Applied Biosystems, Life 
Technologies, Paisley, UK) and 1.6 pM of the second round forward or reverse 
primer. Cycling parameters were 25 three step cycles (96 °C for 10 sec, 50 °C for 5 
sec, 60 °C for 4 mins). The sequencing product was then precipitated using 3 M 
sodium acetate prior to resuspension in HiDi™ formamide (Applied Biosystems, 
Life Technologies, Paisley, UK), and then run on an ABI3130xl. 
 
PCR – 18S rRNA Housekeeping gene 
A housekeeping control was implemented to confirm successful reverse transcription 
of samples and so the presence of amplifiable DNA. cDNA from each sample was 
amplified in a separate PCR reaction using specific primers targeting the 18S 
ribosomal RNA; a gene present in all eukaryotic cells. Briefly, 1 µl of cDNA was 
PCR-amplified in a 14.5 µl reaction containing containing 75 mM Tris-HCl (pH 
8.8), 20 mM (NH4)2SO4, 0.01% (v/v) Tween 20, 0.2 mM each dNTP, 1.5 mM 
MgCl2, 0.025 U Taq polymerase (ABgene), and 5 pM of the 18S rRNA primers and 
18S rRNA competimers (Ambion, UK). Cycling parameters were 95 °C for 10 mins, 
24 three step cycles (30 s at 94 °C, 30 s at 60 °C, 30 s at 72 °C) and 72 °C for 6 
mins. PCR product was analysed by 1.4 % agarose gel electrophoresis (120 V for 60 
mins). Evidence of amplifiable cDNA  gave a band at approximately 489 bp.  
 
PCR – cytochrome b 
Morphological species determination of small mammals was confirmed by 
molecular identification using degenerate cytochrome b (cyt b) primers (Schlegel et 
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al., 2011). Briefly, 1 µl cDNA was PCR-amplified in a 14.5 µl reaction containing 
75 mM Tris-HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01 % (v/v) Tween 20, 0.2 mM each 
dNTP, 1.5 mM MgCl2, 0.025 U Taq polymerase (ABgene) and 10 pM of the CytB 
Uni fw primer and CytB Uni rev primer (Eurofins MWG Operon, Germany) 
(Schlegel et al., 2011). Cycling parameters were 94 °C for 3 mins, 40 three step 
cycles (30 s at 94 °C, 30 s at 47 °C, 1 min at 72 °C) and 72 °C for 10 mins. PCR 
product was analysed by 1.3 % agarose gel electrophoresis (120 V for 60 mins). 
Successful amplification of the cyt b gene gave a band at approximately 947 bp. 
Amplicons were sequenced as described above except using the CytB Uni fw or 
CytB Uni rev primer in the cycle sequencing reaction. 
 
Partial S segment PCR and indirect fluorescent antibody tests (IFAT) were carried 
out by collaborators in Finland (Tarja Sironen: Finnish Forest Research Institute). 
Partial S segment was recovered using the following primers in the reverse 
transcription and the first round of PCR: forward (SF490) 
AARGANAAYAARGGNACN and reverse (SR1157) 
YTGDATHCCCATNGAYTG. Nested PCR followed with primers: forward 
(SF604) ATGAARGCNGADGARHTNACN, and reverse (SR1061) 
CATDATNGTRTTHCTCATRTC. 
 
Phylogenetic analysis 
Multiple nucleotide and amino acid sequence alignments were generated in MEGA5 
(Tamura et al., 2011). Sequence identities were compared using MegAlign 
(Lasergene DNAStar). Bayesian phylogenetic trees were produced in the BEAST 
package of software (Drummond & Rambaut, 2007) with MCMC chain lengths of 
10 million and strict clock.  Optimum substitution models were estimated in MEGA5 
(Tamura et al., 2011). 
 
5.4 Results 
PCR validation and quality assurance (QA) 
The optimised Pan-hantavirus assay was tested using panels of positive material 
requested from the European Virus Archive (EVA). Hantavirus species cDNA 
(DOBV, HTNV and PUUV) were received from Dr Boris Klempa (Slovak Academy 
of Sciences) and positive hantavirus species RNA (HTNV, PUUV, SEOV, TULV) 
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were received from Dr Mark Outlaw (National Collection of Pathogenic Viruses: 
NCPV) (Figure 5.1). Samples included four of the five hantavirus species reported to 
be circulating in Europe and the Hantaan virus prototype species. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Positive control panel, cDNA Hantaan Virus (HTNV) (Strain 76-118), 
Puumala Virus (PUUV) (Strain Sotkamo) and Dobrava-Belgrade Virus (DOBV) 
(Strain Slovakia) (Dr Boris Klempa), RNA for Hantaan Virus (Strain 76-118), 
Puumala Virus,  Seoul Virus (SEOV) (Strain R22), Tula Virus (TULV) (NCPV) 
tested using the Pan-hantavirus RT-PCR assay.  
 
 
The sensitivity of this published pan-hantavirus assay was tested using the Hantaan 
virus (HTNV) (Strain 76-118) provided by Dr Boris Klempa. HTNV viral RNA was 
detected at a dilution of 1:1000 which matched that detected in Dr Boris Klempa‟s 
laboratory. 
 
To validate the assay on actual rodent tissues, bank vole (M. glareolus) lung samples 
were provided in a blind panel that previously had been tested by serology and RT-
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PCR (Professor Heikki Henttonen; Finnish Forest Research Institute). 15/15 
positives and 11/13 negatives were in agreement, however two of the 13 negatives 
were positive in triplicate by our assay suggesting potential increased sensitivity. 
 
Screen results 
With the exception of a single male field vole (B41) collected near the village of 
Tattenhall, Cheshire (Figure 5.2), the lungs from all rodents sampled were negative 
for hantaviral RNA using a nested pan-hantavirus RT-PCR, directed against partial 
polymerase (L) gene sequences. Based on the finite number of each rodent species 
caught and that none were found positive for HV RNA, from this data we cannot rule 
out prevalences less than approximately 1.1 % for wood mice, 2.3 % for brown rats, 
5.8 % for bank voles and 8.2 % for house mice. With regards to the field voles with 
one out of a total eight individuals infected with HV RNA we could expect the true 
prevalence of this virus to be anywhere between 0.3 and 52.7 % based on the 95 % 
confident intervals (Exact binomial test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. The location of the trapping site of B41 within a) United Kingdom and 
b) North West England (urban areas shown in grey). An image of a Field vole (M. 
agrestis) courtesy of E. Oksanen (c). 
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Partial L (371 nucleotides) and S segment (396 nucleotides) sequences were 
retrieved. Established M segment RT-PCR assays were unsuccessful. L and S 
sequences have been deposited with NCBI (Genbank Accession numbers JX316008 
and JX316009 respectively). Table 3 shows nucleotide and amino acid sequence 
identity comparisons between B41 and other members of the Hantavirus genus. The 
Arvicolinae-associated hantaviruses showed the highest similarity to the UK 
sequence at both the nucleotide (65.7 %–78.8 % for S and 76.6 %–77.5 % for L) and 
the amino acid level (66.4 %–86.3 % for S and 80 %-88 % for L) (Table 5.1).    
 
In the partial L tree (Figure 5.3a), B41 viral sequence clusters with Prospect Hill 
virus (PHV) and Tula virus (TULV) with good support, whilst in the partial S tree 
(Figure 5.3b), B41 appears more closely related to the Asian Microtus-associated 
hantaviruses albeit with low posterior probability values.  
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Table 5.1. Similarity (% identity) of B41 partial S and L segment sequences with 
those of other hantaviruses*† 
 
          
  S segment L segment 
Hantavirus nt aa Nt aa 
TOPV 78.8 86.3 n/a n/a 
Fusong 75.0 80.9 77.2 80.0 
KHAV 74.7 85.5 n/a n/a 
PUUV 73.7 80.2 76.6 84.8 
HOKV 73.5 79.4 76.9 84.8 
PHV 68.7 73.3 77.5 88.0 
TULV 65.7 66.4 77.5 86.4 
SNV 58.1 53.4 71.9 78.4 
SWSV 56.3 48.1 68.0 70.4 
ANDV 55.8 51.9 72.2 81.6 
DOBV 52.8 42.7 63.3 66.4 
SEOV 52.8 42.3 63.6 68.8 
SAAV 51.8 43.5 63.9 65.6 
HTNV 51.5 41.2 66.9 69.6 
TPMV 49.2 41.2 63.9 63.2 
MGB/1209 n/a n/a 65.0 62.4 
 
 
*S, small; L, large;  TOPV, Topografov virus (AJ011646); Fusong (EU072481 
and FJ170807); KHAV, Khabarovsk  (U35255); PUUV, Puumala virus 
(M32750 and M63194); HOKV, Hokkaido virus (AB675463 and AB675455); 
PHV, Prospect Hill virus (M34011 and EF646763); TULV, Tula virus 
(NC005227 and NC005226); SNV, Sin Nombre virus (NC005216 and L37901); 
SWSV, Seewis virus (GQ293136 and EF636026); ANDV, Andes virus 
(AF291702 and AF291704); DOBV, Dobrava-Belgrade (AY961615 and 
GU904039); SEOV, Seoul virus (AY273791 and X56492);  SAAV, Saaremaa 
virus (AJ616854 and AJ410618); HTNV, Hantaan virus (NC005218 and 
NC005222); TPMV, Thottapalayam virus (AY526097 and NC010707); 
MGB/1209, Magboi/1209 virus (JN037851); n/a, sequence not available. 
†396 nucleotides (nt) of the S segment (positions 620-1015), and 371 nt of the L 
segment (positions 2962-3332) and the deduced amino acid (aa) sequences (131 
aa, position 194-324 of the nucleocapsid protein; 123 aa, position 976-1098 of 
the viral RNA-dependent RNA polymerase) have been compared using 
MegAlign (Lasergene DNAStar). Fragment positions were defined according to 
complete sequences of PUUV strain CG1820. 
  
105 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Bayesian phylogenetic trees using the models HKY+Gamma for partial L segment sequences n = 19 (a) and  GTR+Gamma for partial S segment 
n = 39 (b, overleaf) within the BEAST package of software (Drummond & Rambaut, 2007). The trees are drawn to scale, with branch lengths measured in the 
number of substitutions per site. The numbers at each node are posterior probabilities. All Effective Sample Size values exceeded 150 for partial L and 1600 
for partial S. The scale bar indicates nucleotide substitutions per site. The phylogenetic position of B41 is shown in relation to representative hantaviruses a) 
and more closely related Arvicolinae-associated hantaviruses b). All positions containing gaps and missing data were eliminated. Genbank accession numbers 
are shown next to taxa names. B41; VLAV, Vladivostok virus; TOPV, Topografov virus; KHAV, Khabarovsk virus; PUUV, Puumala virus; HOKV, 
Hokkaido virus; MUJV, Muju virus; PHV, Prospect Hill virus; ISLAV, Isla Vista virus; TULV, Tula virus; LANV, Laguna Negra virus; ANDV, Andes virus; 
SNV, Sin Nombre virus; NYV, New York virus. 
9
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Figure 5.3. continued. 
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Blood collected from B41 was sent to the reference laboratory in Finland (Professor 
Heikki Henttonen‟s Research group). The blood was found positive for hantavirus-
specific antibodies (indirect fluorescent antibody test using Puumala antigen (Vaheri 
et al., 2008) suggesting that there is cross reactivity between the two viruses, well-
known for hantaviruses within the same host subfamilies (Vaheri et al., 2008). 
Hantavirus RNA was detected in the kidney but not the liver of B41 nor the lung, 
liver and kidney of the seven other field voles. Degenerate cytochrome b gene PCR 
and sequencing (Schlegel et al., 2011) was employed to confirm the morphological 
identification of the field voles (B41 cyt b Genbank accession no. KC222031). 
 
5.5 Discussion 
Phylogenetic analyses of partial L sequences (Figure 5.3a) and partial S sequences 
(Figure 5.3b) confirm the inclusion of B41 as a distinct member of the Arvicolinae-
associated hantaviruses. Although phylogenetic position cannot be fully resolved 
based on these partial sequences and the differences in tree topologies most likely 
reflect the different composition of the sequence datasets. The nucleotide and amino 
acid sequence divergence between B41 and the most related hantaviruses 
corresponds to that typically found between different hantavirus species (Klempa et 
al., 2006). In addition, the phylogenetic analysis of the B41 S and L sequences 
further supports it as a distinct hantavirus. As such we propose to name this novel 
virus, Tatenale Virus (TATV), representing the name of the village in which it 
originated as it was first recorded in the Doomsday book of 1086. This was to avoid 
any negative connotations for the area. 
 
Microtus agrestis has not previously been shown to be a primary carrier of a specific 
hantavirus although recent studies suggested an involvement in the maintenance of 
TULV infection in Germany (Schmidt-Chanasit et al., 2010).  M. agrestis is one of 
the most numerous mammals of mainland Britain, with estimated populations 
exceeding 75 million (Harris & Yalden, 2008), but it mainly inhabits ungrazed 
grassland and as such may pose a lower public health risk than other more 
synanthrophic hosts. Further investigations are required to determine if M. agrestis is 
the only or main reservoir host of this novel virus. More extensive targeted 
surveillance of field voles in the UK, using TATV specific RT-PCR and IFAT, is 
necessary to provide an estimate of virus prevalence, to determine the zoonotic 
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morbidity of TATV and to confirm if M. agrestis is the reservoir host of this novel 
virus. Such data are essential to inform policy and determine the relative risks to 
human and animal health. Current knowledge of other Microtus-borne hantaviruses 
suggests that while they may infect man, generally their pathogenic potential is low 
(Vaheri et al., 2012). Future work will also involve attempts to isolate TATV and 
generate full genome sequence. 
 
Despite the recent confirmation of SEOV in localised UK brown rats we did not find 
any evidence of SEOV in rodents caught around the North West. One explanation 
for this might be that if SEOV infected rats have only been introduced via the ports 
in the Humber region of the UK then it is possible that the virus has not had long 
enough to effectively spread to the North West. Although suggestive evidence from 
past UK human reports, if caused by SEOV give the impression of a wider 
distribution e.g. Glasgow (Walker et al., 1984) and Nottingham (Watson et al., 
1997). There is also the possibility that these infected rats are in some way 
genetically different to non-infected rats making them more suitable carriers. The 
port of Liverpool is the largest on the west coast of Britain and is the third busiest 
port in the UK. Liverpool has strong import/export links with several countries with 
reported rodent and human SEOV cases including China and the USA (Steve 
Seddon, Mersey Port Health Authority, pers. comms.). 
 
Due to the broad clinical features of hantavirus disease, it is likely that many UK 
human cases would be misdiagnosed. The confirmation of our novel hantavirus and 
the recently reported SEOV case in indigenous wildlife in the UK may promote the 
inclusion of a hantavirus differential when patients present with acute renal failure, 
undiagnosed febrile illness and have had previous exposure to rodents (Fhogartaigh 
et al., 2011).  
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Chapter 6. Genetic comparison of Seoul hantavirus in Rattus norvegicus in 
Lyon,  France 
 
6.1 Abstract 
Hantaviruses (family Bunyaviridae, genus Hantavirus) are single-stranded RNA 
viruses, which are transmitted to humans primarily via inhalation of aerosolised 
virus in contaminated rodent urine and faeces. Whilst infected reservoir hosts are 
asymptomatic, human infections can lead to two clinical manifestations, 
haemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary 
syndrome (HCPS), with varying degrees of morbidity and mortality. Surveillance in 
Europe has detected six rodent-borne hantaviruses; Dobrava-Belgrade Virus 
(DOBV), Saaremaa virus (SAAV), Seoul virus (SEOV), Puumala virus (PUUV), 
Tatenale virus (TATV) and Tula virus (TULV). The prevalence of rodent and human 
cases of SEOV in Europe are considered to be low, and speculated to be driven by 
the sporadic introduction of infected brown rats (Rattus norvegicus) via ports.  
Between October 2010 and March 2012, 128 brown rats were caught at sites across 
the Lyon region in France. SEOV RNA was detected in the lungs of 14 % (95 % CI 
8.55 – 21.31) of brown rats tested using a nested pan-hantavirus RT-PCR 
(polymerase gene). We did not detect any evidence of a genetic difference between 
infected and non-infected rats (cytochrome b gene). Our findings and the recent 
detection of SEOV in UK brown rats, suggest that SEOV is more prevalent in 
European brown rats and may contribute to a greater number of the reported HFRS 
cases in Europe than previously believed. 
 
6.2 Introduction 
Hantaviruses (family Bunyaviridae, genus Hantavirus) are single-stranded RNA 
viruses. Unlike other members of the Bunyaviridae, hantaviruses are not transmitted 
by arthropods but primarily by rodents of the families Cricetidae and Muridae, 
although insectivore and bat hosts have recently been reported (Klempa et al., 2007; 
Weiss et al., 2012). Each hantavirus appears to be adapted and largely restricted to 
an individual reservoir host species, implying that they have co-evolved, although 
phylogenetic analyses suggests that this apparent co-evolution may be more 
attributed to recent preferential host switching and local adaptation (Ramsden et al., 
2009). 
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Transmission to humans is primarily via inhalation of aerosolised virus in 
contaminated rodent urine and faeces. Whilst infected reservoir hosts are 
asymptomatic, human infections can lead to two clinical manifestations, 
haemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary 
syndrome (HCPS), with varying degrees of morbidity and mortality (Vaheri et al., 
2012). Surveillance in Europe has detected six rodent-borne hantaviruses; Dobrava-
Belgrade virus (DOBV), Saaremaa virus (SAAV), Seoul virus (SEOV), Puumala 
virus (PUUV), Tatenale virus (TATV) (Pounder et al., 2013) and Tula virus (TULV) 
plus two insectivore-borne hantaviruses; Seewis virus (SWSV) and Nova virus 
(NVAV ) (Heyman et al., 2011; Olsson et al., 2010; Vaheri et al., 2012). The 
relative geographic distribution of each hantavirus is defined by their reservoir host 
(Olsson et al., 2010). The most common and widespread hantavirus across northern, 
central and eastern Europe is PUUV, which is associated with the mildest form of 
HFRS (Vaheri et al., 2012). 
 
The Norwegian/brown rat (Rattus norvegicus) is a reservoir host for Seoul virus, a 
cause of mild to moderate HFRS disease in humans (Vaheri et al., 2012). Brown rats 
are a cosmopolitan species and thus provide the potential to spread SEOV 
worldwide. They represent the predominant and widely distributed host of hantavirus 
in China, where, a total of 1,557,622 cases of HFRS were reported in humans 
between 1950–2007 with 46,427 deaths (3 %) (Lin et al., 2012; Zhang et al., 2009). 
 
Recent data suggests that the brown rat originated from northern China and only 
migrated to the rest of the world within the last two centuries (Lin et al., 2012). It is 
proposed that this recent radiation also brought with it the distribution of SEOV from 
China (Lin et al., 2012). To date, confirmed human SEOV infections have been 
reported in Asia (Japan (Kariwa et al., 2000), South Korea (Kim et al., 1995), China 
(Song, 1999; Zhang et al., 2009)) and the Americas (USA (Glass et al., 1994), Brazil 
(Iversson et al., 1994)). Within Europe however, beyond laboratory acquired 
infections (Shi et al., 2003), there has been only been one SEOV confirmed HFRS 
case where SEOV RNA had been detected in a patients serum in Lyon, France 
(Macé et al., 2013). There have also been a further three human cases in the UK 
which are presumed SEOV infections due to suspected or known exposure to SEOV 
infected rats (Jameson et al., 2013a; Jameson et al., 2013b; Taori et al., 2013) and a 
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single case confirmed serologically by virus neutralisation assay (vNA) in Lyon 
(Lundkvist personal comment; (Heyman et al., 2004)). However, rat seroprevalences 
of 10-78.9 % and 27.1 % to SEOV antibodies have been seen in France (Heyman et 
al., 2004) and Belgium (Heyman et al., 2009a), respectively. SEOV was confirmed 
as the etiological agent by RT-PCR in both studies. 
 
This study aimed to determine the prevalence of SEOV in wild rats (R. norvegicus) 
trapped in and around Lyon, France and analyse any resulting molecular 
epidemiological data. We also assessed the usefulness of mitochondrial cytochrome 
b (cyt b) gene analysis to determine if the infected rats were non-indigenous to Lyon 
(a major port) and thereby support a relatively recent importation into France. 
 
6.3 Methods 
Field work 
The survey was subdivided in two 6-month-periods. The first period aimed at rural 
rat sampling which was conducted from October 2010 to February 2011. All sites 
were located within 15 km of Rhône-Alpes (Figure 6.1a). The second aimed at urban 
rat sampling which was conducted from October 2011 to March 2012 in Lyon 
(Figure 6.1a). During the two periods, 184 free living Norway rats (R. norvegicus) 
were trapped from which 128 were screened for hantaviruses by RT-PCR. Rats were 
trapped using small (28 cm x 9 cm x 9 cm) or large (50 cm x 15 cm x 15 cm) single 
catch rat traps. Captured rats were transported to the laboratory where live rats were 
immediately anaesthetised using Isoflurane and sacrificed by cervical dislocation 
whereas dead rats were frozen (-20 °C) and thawed on the day of the dissection. 
Lungs were collected from different lobes. Samples were directly stored at -80 °C 
(rural sampling) or -20 °C (urban sampling) until their shipping to the University of 
Liverpool where they were stored at -80 °C. 
 
Rats provided for this study were trapped for the purpose of pest control (agreement 
no. 69-1810). They were euthanized and used (agreement no. 69-020931) according 
to ethical rules supervised by the ethical committee of VetAgro Sup and European 
regulation (Directive EU 86/609). 
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Figure 6.1. The locations of the trappings sites within a) France and b) Rhône 
department. SEOV infected groups „Lyon I, II and III‟ are represented by a star, 
triangle and blocked out circles, respectively. Non-infected individuals are marked 
by open circles. 
 
 
Screening 
RNA extraction 
50-100 mg of liver tissue was homogenised in 1 ml TRIzol® Reagent (Invitrogen, 
Life Technologies, Paisley, UK) with QIAGEN Stainless steel beads (5 mm) using a 
QIAGEN TissueLyser (Qiagen, UK) for 2 mins at 30 Hz. RNA was extracted from 
the homogenate as described in the Invitrogen TRIzol® Reagent instructions for 
 
a) 
b) 
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animal tissues (Invitrogen, Life Technologies, Paisley, UK). The RNA was diluted 
1:10 in sterile distilled water and quantified using a NanoDrop ND-1000 
spectrophotometer (LabTech International, UK) and stored at -80 °C until reverse 
transcription. 
 
cDNA synthesis 
RNA was reverse transcribed following a standard first strand cDNA synthesis 
protocol (Invitrogen, Life Technologies, Paisley, UK). Briefly, approximately 1 µg 
of RNA was reverse transcribed in a 20 µl reaction containing 50 ng/µl random 
hexamers, 10 mM dNTP mix (10 mM each of dATP, dGTP, dCTP and dTTP at 
neutral pH), 5X First strand buffer, 0.1 M DTT and 200 U SuperScript™ III Reverse 
Transcriptase (Invitrogen, Life Technologies, Paisley, UK). Cycling parameters were 
65 °C for 5 mins, 50 °C for 60 mins and 70 °C for 15 mins in a Techne TC-5000 
Thermal Cycler. The cDNA was stored at -20 °C. 
 
Hantavirus PCR 
Screening of the rodent lung samples for hantaviral RNA was performed using a 
nested pan-hantavirus PCR directed against partial polymerase (L) gene sequences 
(Klempa et al., 2006). Briefly, 2 µl cDNA was synthesised in a 14.5 µl reaction 
containing 75 mM Tris-HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01 % (v/v) Tween 20, 
0.2 mM each dNTP, 1.5 mM MgCl2, 0.025 U Taq polymerase (ABgene) and 10 
pmol (each) of HAN-L-F1 and HAN-L-R1 primers (Eurofins MWG Operon, 
Germany) (Klempa et al., 2006). Cycling parameters were 95 °C for 15 mins, 40 
three step cycles (30 s at 95 °C, 45 s at 53 °C, 30 s at 72 °C) and at 72 °C for 6 mins. 
 
Primers HAN-L-F2 and HAN-L-R2 were used in the second round PCR (Eurofins 
MWG Operon, Germany) (Klempa et al., 2006). Thermal cycling conditions are as 
described above. Five µl of PCR product were analysed by 1.5 % agarose gel 
electrophoresis (120 V for 70 mins). Hantavirus positive samples gave a band at 
approximately 452 bp after the first round and 390 bp after the second round. 
 
cyt b PCR 
Morphological species determination of small mammals was confirmed by 
molecular identification using degenerate cyt b primers (Schlegel et al., 2011). 
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Briefly, 1 µl cDNA was PCR-amplified in a 14.5 µl reaction containing 75 mM Tris-
HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01 % (v/v) Tween 20, 0.2 mM each dNTP, 1.5 
mM MgCl2, 0.025 U Taq polymerase (ABgene) and 10 pM of the CytB Unifw 
primer and CytB Uni rev primer (Eurofins MWG Operon, Germany) (Schlegel et al., 
2011). Cycling parameters were 94 °C for 3mins, 40 three step cycles (30 s at 94 °C, 
30 s at 47 °C, 1 min at 72 °C) and 72 °C for 10 mins. PCR product was analysed by 
1.3 % agarose gel electrophoresis (120 V for 60 mins). Successful amplification of 
the cyt b gene gave a band at approximately 947 bp. 
 
PCR product purification and DNA Sequencing 
Primers and unincorporated nucleotides were removed from PCR products using an 
ExoSAP digest. Five µl PCR product was added to 2 µl mix containing 10X RX 
buffer, 0.2 U Shrimp Alkaline phosphatase (USB, UK) and 1 U Exonuclease I (New 
England BioLabs, UK). Cycling parameters were 37 °C for 45 mins, 80 °C for 15 
mins. The cycle sequencing reaction was set up using the BigDye® Terminator v3.1 
Cycle Sequencing kit. One µl of ExoSAP product was added to a 9 µl reaction mix 
containing 5X sequencing buffer, 0.75 µl BigDye 3.1 (Applied Biosystems, Life 
Technologies, Paisley, UK) and 1.6 pM of either LV forward, LV reverse, CytB 
Unifw or CytB Uni rev primer. Cycling parameters were 25 three step cycles (96 °C 
for 10 sec, 50 °C for 5 sec, 60 °C for 4 mins).The sequencing product was then 
precipitated using 3 M sodium acetate prior to resuspension in HiDi™ formamide 
(Applied Biosystems, Life Technologies, Paisley, UK), and then run on an 
ABI3130xl. 
 
Phylogenetic analysis 
Multiple nucleotide sequence alignments were generated in MEGA5 (Tamura et al., 
2011). Sequence identities were compared using Geneious 5.6.5 (Biomatters: 
www.geneious.com, date accessed: 1/8/12). Maximum likelihood phylogenetic trees 
were produced in MEGA5 (Tamura et al., 2011) with bootstrap replications of 
10,000 (Felsenstein, 1985).  Optimum substitution models were estimated in 
MEGA5 (Tamura et al., 2011).  
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454 method 
Viral specific reads from one positive sample, LYO852, were obtained directly from 
lung tissue. Briefly, TRIzol® extracted viral RNA was depleted of host genomic 
DNA using RNase-free DNAse (Qiagen, UK) and host ribosomal RNA was depleted 
using Terminator™ 5'-Phosphate-Dependent Exonuclease (Epicentre 
Biotechnologies). The RNA was fragmented, a random-primed cDNA library was 
made and run using the Roche 454 GS FLX System. The sequencing data were 
initially assembled in the GS de novo assembly software (Roche). Subsequently, 
previously published SEOV sequences were used to map specific reads from the 
original raw data using GS Reference Mapper (Roche). 
 
6.4 Results 
Screening 
A total of 84 brown rats were caught from urban areas and 44 from rural areas 
around Lyon (Table 6.1). Screening of rat lung samples tested in triplicate for the 
presence of Seoul hantavirus RNA showed an overall prevalence of 14.1 % (18/128) 
(Exact binomial test 95 % confidence intervals, 8.55 – 21.31). There was a male bias 
of 2:1 in the infected individuals (11 adult males, one juvenile male, one pregnant 
female and five adult females). The proportion of all males infected was larger than 
females, 16.4 % and 11.3 % respectively, but this was not significant (Pearson's Chi-
squared test, χ2 = 0.6568, df = 1, P = 0.4177). On separating the infected adults 
according to habitat type, there was no significant difference found between males 
and females in urban areas (Pearson's Chi-squared test χ2 = 0.0854, df = 1, P = 0.77). 
However the proportion of males infected in rural areas was significantly larger than 
that of females (Fisher's Exact Test, P < 0.05) (Table 6.2).  
 
All 18 RT-PCR positive rats were selected for genetic analysis and partial sequences 
of the L segment (317 bp) were recovered. Eight variable sites were located within 
this partial sequence. Phylogenetic analysis of the SEOV-positive brown rats shows 
that they divide into three clusters: Lyon I, II and III (Figure 6.1b & Figure 6.2). 
Analysis of all SEOV partial L segments shows highest identity to the Belgium 
SEO/Belgium/Rn895/2005 strain (JQ898108) (98.0-98.8 %) (Heyman et al., 2009a). 
Lyon I sequences (LYO903 and LYO906) were somewhat more divergent from the 
other Lyon sequences (0.5-1.4 %). All 18 RT-PCR L sequences clustered with 
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previously described Lineage #7 (Plyusnina et al., 2004), with moderate bootstrap 
support of at least 62 (Figure 6.2). 
 
 
 
Table 6.1. Field sample break down of caught urban and rural brown rats (R. 
norvegicus) by gender and age. 
 
 
 
 
 
 
 
 
 
 
Table 6.2. Gender comparison of SEOV prevalence in adult rats from urban and 
rural areas. 
 
 Male Female 
 Total Infected (%) Total Infected (%) 
Urban 35 20.0 22 27.3 
Rural 11 36.4 19 0.0 
 
 
 
cyt b 
Partial sequences of the cyt b gene (833 bp) were recovered from the 18 infected 
samples and 15 non-infected samples. Eighteen variable sites were located within 
this partial sequence. Pairwise comparisons among all sequences (including out 
groups) ranged from 0 to 11.9 %. All Lyon cyt b sequences in this study had an 
average genetic distance of 0.3 % (ranging between 0 to 1.0 %). Compared to group 
  Male Female   
 Habitat Adult Juvenile Adult Juvenile Total 
Urban 35 22 22 5 84 
Rural 11 5 19 7 42
a
 
Total 46 27 41 12 126 
a
Two additional juvenile rats gender not known 
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A (non-Chinese and Chinese non-mountainous Seoul virus variants, Lin et al., 2012) 
members, Lyon sequences had an average distance of 0.4 % (range between 0 to 1.0 
%) whereas to group B (Chinese mountainous Seoul virus variants, Lin et al., 2012) 
there was an average of 5.5 % (range 5.4 to 5.8 %).  The average genetic distance 
between Lyon R. norvegicus and the outgroup R. tanezumi and R. rattus was 11.3 % 
(ranging from 10.8 to 11.9 %). Infected rats (Figure 6.3: In red bold) formed two 
main clusters, one including Lyon III individuals and the other Lyon I and II. All 
partials regardless of clusters assembled with group A sequences (Figure 6.3). Partial 
cyt b sequences were also retrieved from n = 56 brown rats collected for Chapters 3 
and 5, providing UK representatives for analysis. 
 
454 S and M segment sequence output and assembly statistics 
De Novo assembly of LYO852 reads yielded 59 contigs (consisting of 73,105 reads, 
totalling 24,730,464 bp) representing  82 % total reads, with a mean length of 702 bp 
(ranging between 105-2920 bp). There were 15 contigs ≥500 bp. Based on BLAST 
identity searches all contigs were host or mycoplasma sequences. Mapping of the 
reads using GS Reference Mapper (Roche) with published SEOV genome sequences 
identified 44 (0.03 %) SEOV specific reads yielding 9 contigs in total for LYO852. 
Two partial nucleocapsid (S) gene contigs were retrieved, of 715 and 786 bp, and  
showed greatest identity to Seoul strain Singapore/06(RN46) (98 %) and 
SEO/Belgium/Rn895/2005 (98 %), respectively. Three partial glycoprotein (M) gene 
contigs were retrieved, of 987, 1,735 and 612 bp and showed greatest identity to 
Seoul strain Singapore/06(RN46) (98 %), Seoul strain 5CSG (98 %) and 5CSG (98 
%), respectively. However, contig 2 (1,735 bp) was 99 % identical over 283 nt to a 
previously published Lyon colony rat partial M sequence (Heyman et al., 2004). 
Four partial polymerase (L) gene contigs were retrieved, of 459, 603 and 740 bp, 
with greatest identity to lineage #4 Seoul strain 80-39 (96 %) and one contig (1,564 
bp) had greatest identity to lineage #3 Seoul strain DPRK08 (97 %) (Wang et al., 
2000). All S (Figure 6.4 & data not shown), M (data not shown) partials for LYO852 
clustered within lineage #7 (Plyusnina et al., 2004). Total coverage for each of the 
three segments of LYO852 was 84.8 % (S), 91.3 % (M) and 51.5 % (L). 
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Figure 6.2. Maximum likelihood tree using the model T92+Gamma (Tamura, 1992) 
for SEOV partial L segment sequences n = 23 in MEGA5 (Tamura et al., 2011). The 
trees are drawn to scale, with branch lengths measured in the number of substitutions 
per site. The scale bar indicates nucleotide substitutions per site. Only bootstrap 
support of >70 % are shown. Positions with less than 95 % site coverage were 
eliminated. There were a total of 317 positions in the final dataset. The phylogenetic 
positions of groups Lyon I, II and III are shown in relation to representative Seoul 
strains. LYO726 partial L sequence was identical to LYO733, 737 and 757. LYO799 
partial L sequence was identical to LYO837, 838, 839, 843, 845, 848, 852, 853, 884 
and 871. Genbank accession numbers are shown next to taxa names. 
 
 
 
 HuBJ20 China HM748805
 Z37 China AF285266
 DPRK08 North Korea JX853574
 Humber UK JX879770
 L99 China AF288297
 80-39 Korea NC_005238
 Jakarta-Rn137-2000 Indonesia JQ934829
 LYO835 France  n = 1
 LYO799 France  n = 11
 GIV726 France  n = 4
 LYO906 France  n = 1
 LYO903 France  n = 1
 REPLONGES/Hu/FRA/2012/12-0882 France
 SEO-Belgium-Rn895-2005 Belgium JQ898108
 PP21 Cambodia JN116269
 L0199 Laos HQ992814
 Dobrava-Belgrade virus NC_005235
 Saaremaa virus AJ410618
 Hantaan virus NC_005222
 Sin Nombre virus L37901
 Andes virus NC_003468
 Tula virus AJ005637
 Puumala virus Z66548
Lineage 3 
Lineage 1 
Lineage 7 
Lineage 4 
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Figure 6.3. Maximum likelihood tree using the model (continued overleaf)  
 K45Greenbank UK
 Wild/Swe Sweden FJ919765
n = 13 LYO797Urban France
n = 3 GIV417Rural France
n = 1 LYO845Urban France
n = 1 LYO887Urban France
 ShenyangRn168 China GU592988 
 C179Southport UK
n = 1 LYO799Urban France
n = 1 GIV464Rural France
n = 1 LYO884Urban France
n = 1 LYO838Urban France
n = 1 LYO874Urban France
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Figure 6.3. continued. HKY+Gamma (Hasegawa et al., 1985) for partial 
cytochrome b sequences n = 72 in MEGA5 (Tamura et al., 2011). The trees are 
drawn to scale, with branch lengths measured in the number of substitutions per site. 
The scale bar indicates nucleotide substitutions per site. Only bootstrap support of 
>70 % are shown. Positions with less than 95 % site coverage were eliminated. 
There were a total of 833 positions in the final dataset. The phylogenetic positions of 
Lyon R. norvegicus are shown in relation to representative R. norvegicus sequences. 
Representative Lyon rats are highlighted in bold, and those that include at least one 
infected individual are red bold. Genbank accession numbers are shown next to taxa 
names.
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Figure 6.4. Maximum likelihood tree using the model TN93+Gamma (Tamura & Nei, 1993) for SEOV partial S segment sequences n = 24 in 
MEGA5 (Tamura et al., 2011). The trees are drawn to scale, with branch lengths measured in the number of substitutions per site. The scale bar 
indicates nucleotide substitutions per site. Only bootstrap support of >70 % are shown. Positions with less than 95 % site coverage were 
eliminated. There were a total of 702 positions in the final dataset. The phylogenetic position of Lyon852 is shown in relation to representative 
Seoul strains. Genbank accession numbers are shown next to taxa names. 
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6.5 Discussion 
The prevalence of SEOV hantaviral RNA in Lyon rats of 14.1 % shown in this study 
falls within the range of seroprevalences found in studies from Argentina (0 - 26 %) 
(Cueto et al., 2008), Baltimore (52 %) (Easterbrook et al., 2005), Belgium              
(7.6 - 50 %) (Heyman et al., 2009a), Cambodia (20.9 %) (Reynes et al., 2003), 
China (13.5 %) (Li et al., 1995), Indonesia (10 %) (Ibrahim et al., 1996), Northern 
Ireland (21.6 %) (McCaughey et al., 1996), South Korea (9.6 %) (Kim et al., 2007) 
and Vietnam (14 %) (Koma et al., 2012). The previous French SEOV investigation 
reported a seroprevalence as large as 78.9 % (Heyman et al., 2004). This figure 
however relates to a study with two subgroups each containing ten animals, whereas 
our study involved a much larger sample size (n = 128). Furthermore, we employed 
molecular methods to detect viral RNA rather than the more variable serological 
detection of antibodies. 
 
Within the sample group of SEOV infected individuals, we only observed a male 
biased ratio amongst the adult rural samples. A male biased ratio amongst SEOV 
infected rats is not uncommon however, and has been reported on several occasions 
(Cueto et al., 2008; Glass et al., 1988; Klein et al., 2000). Whilst neither male nor 
female rats are believed to be more susceptible to Seoul virus infection, males do 
shed the virus for a longer duration in their urine, faeces and saliva (Klein et al., 
2000) and so the viral RNA may be detectable for longer in the host tissues. In 
addition the primary route of transmission between adult males is thought to be 
through wounds (Hinson et al., 2004), so it has been suggested that the likelihood of 
males acquiring the Seoul virus is greater due to them having more aggressive 
encounters (Klein et al., 2000). Perhaps contact with con-specifics occurs less 
frequently in rural areas and when it does tends to be male-male interactions. 
 
Despite their disparate isolation, most SEOV variants published to date are 
genetically homogenous with up to 95 % nucleotide sequence identity (Zhang et al., 
2009) making it difficult to determine source of introduction. Phylogenetic analysis 
of the SEOV partial L segment show Lyon sequences cluster by location. Lyon I 
sequences, were more divergent from the other two groups (Figure 6.2). S and M 
available partial segments of the Lyon samples supported their grouping within 
lineage #7 along with all other European strains except for the recently isolated 
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„Humber‟ strain in the UK (Jameson et al., 2013a). Surprisingly, this strain is more 
similar to the UK laboratory-acquired strain IR461 despite the laboratory rats 
originating from Japan via Belgium (Jameson et al., 2013a; Shi et al., 2003). 
Interestingly, whilst Lyon I sequences were more divergent from both Lyon II and 
III in the partial L segment, in the cytochrome b gene, Lyon I rats were more similar 
and clustered with Lyon II rats than either were to Lyon III rats. Although 454 
pyrosequencing did not deduce the complete genome for LYO852, we were able to 
obtain reads from all three segments, the S and M partials substantiate the RT-PCR L 
gene data as clustering with lineage #7 (Plyusnina et al., 2004). However the L 
partial sequences obtained from the 454 cluster with lineage #3 and #4 (Wang et al., 
2000). Good coverage of sequence information was obtained for the S and M 
segments (>84 %), and whilst only 50 % was recovered for the L segment this 
actually corresponds to >3,000 bp. The low level of viral reads in the RNA pool (0.03 
%) possibly reflects the low viral load in the organ at the time of sampling.  
 
The cytochrome b gene is a useful target for species recognition as it has a tendency 
to be more reliable than morphological characteristics. Genetic divergences typically 
seen in the cytochrome b gene between individuals at the species level and indicative 
of species recognition is >11 % (Bradley & Baker, 2001), and we support this with a 
comparison of R. norvegicus against the outgroups (11.3 %) (R. tanezumi and R. 
rattus). Several studies have looked at the genetic variation expected in the cyt b 
gene within rodent species and found divergences of 0 – 8.1 % (Gering et al., 2009; 
Myers et al., 1995; Smith & Patton, 1991; Tiemann-Boege et al., 2000; Van Daele et 
al., 2007). The brown rat has been found worldwide however it only radiated in the 
last few centuries with the aid of human globalisation (Lin et al., 2012). Very few 
rodent species exhibit such an extensive distribution so it makes sense to compare 
the divergences of the brown rat with a species that exhibits much greater mobility 
than rodents in general i.e. Chiroptera. Single bat species have been found widely 
segregated around the world and studies have investigated the genetic divergence 
between these and have found evidence of greater differences. For example, Myotis 
muricola populations in the Malay Archipelago have found divergences on average 
of 8 and 9.5 % (ranging between 0-16.4 %) (Wiantoro et al., 2012), and Miniopterus 
schreibersii populations in Europe and South Africa were found to be divergent by 
10.5 % (Stadelmann et al., 2004). Lin et al., (2012) previously described the 
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dispersal of R. norvegicus as two clusters, cluster A being composed of all non 
Chinese, and Chinese non-mountainous SEOV variants and cluster B composed of a 
cohort that originated from mountainous areas of China. Our data support the two 
lineages proposed with genetic divergences confirming the placing of Lyon brown 
rats within cluster A (divergence 0.4 %), rather than to cluster B (5.5 %). 
Considering the brown rat is a cosmopolitan species it has surprisingly lower genetic 
divergence than expected. It was also thought that infected rats may be genetically 
different to non-infected rats making them more likely hosts for SEOV. With 
evidence from our partial cyt b sequences we could not confidently support the 
theory that SEOV infected rats were continually being introduced via boats etc. 
Rather infected and non-infected rats were found in both clusters (Figure 6.3). 
 
We present here not only further confirmation of the circulation of Seoul virus in and 
around Lyon, France but we also demonstrate a revised SEOV prevalence estimate 
in brown rats using molecular methods. All SEOV RT-PCR L partials and the 
available S and M partial segments were consistent in their support for being placed 
among lineage #7 along with European and Southeast Asian strains, although the 
four partial L sequences retrieved from De Novo sequencing did not show this, rather 
identities were closer to lineage 3 and 4 Seoul strains (Wang et al., 2000). To 
confidently resolve the L segments lineage, more sequence data would be required. 
There is no evidence of SEOV infected rats being different to non-infected rats in the 
partial cytochrome b gene. SEOV has been found circulating in brown rats in France, 
Belgium and the UK and it is to be expected that it will also be circulating in other 
European countries. This is the first large scale molecular survey of SEOV in urban 
and rural rats in Europe. We have confirmed a greater prevalence in European brown 
rats than previously believed. Our data may suggest a greater role of SEOV in 
European HFRS cases than previously thought, warranting further surveillance. 
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Chapter 7. Seoul virus in Pet Rats 
 
7.1 Abstract 
Wild brown rats (Rattus norvegicus) are reservoirs for Seoul virus (SEOV), a cause 
of mild to moderate HFRS disease in humans. Currently the prevalence of rodent and 
human cases of SEOV in Europe are considered to be low. However, following two 
separate suspected human hantavirus cases, SEOV has been detected in wild brown 
rats (Rattus norvegicus) in the Humber region of the UK and a pet rat in North 
Wales. In 2012, 21 pet rats (R. norvegicus) from a breeding colony in Oxfordshire, 
the origin of the North Wales pet rat, were screened for hantaviral RNA using a pan-
hantavirus RT-PCR. Multiple organs were screened from a single individual to 
investigate SEOV tropism. SEOV RNA was detected in the lungs and kidneys of 81 
% of pet rats tested and all but one of the organs from the single individual (liver). 
Sequence analysis showed it to be most similar to the recently isolated SEOV 
Humber strain (97 %). No evidence was detected for a genetic difference between 
pet rats and wild UK rats (cytochrome b gene). Domesticated rats are not generally 
considered a public health problem, however these findings suggest that hantaviruses 
may pose a greater risk than previously believed. 
 
7.2 Introduction 
Hantaviruses (family Bunyaviridae, genus Hantavirus) are single-stranded RNA 
viruses. Unlike other members of the Bunyaviridae, hantaviruses are not transmitted 
by arthropods but primarily by rodents of the families Cricetidae and Muridae, 
although insectivore and bat hosts have recently been reported (Klempa et al., 2007; 
Weiss et al., 2012). Each hantavirus appears to be adapted and largely restricted to 
an individual reservoir host species, implying that they have co-evolved, although 
phylogenetic analyses suggests that this apparent co-evolution may be more 
attributed to recent preferential host switching and local adaptation (Ramsden et al., 
2009). 
 
Transmission to humans is primarily via inhalation of aerosolised virus in 
contaminated rodent urine and faeces. Whilst infected reservoir hosts are 
asymptomatic, human infections can lead to two clinical manifestations, 
haemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary 
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syndrome (HCPS), with varying degrees of morbidity and mortality (Vaheri et al., 
2012). Zoonotic surveillance projects throughout Europe have detected five rodent-
borne hantaviruses; Dobrava-Belgrade (DOBV), Saaremaa (SAAV), Seoul (SEOV), 
Puumala (PUUV) and Tula (TULV) plus two insectivore-borne hantaviruses; Seewis 
(SWSV) and Nova (NVAV) (Olsson et al., 2010; Vaheri et al., 2012). The relative 
geographic distribution of each hantavirus is defined by their reservoir host (Olsson 
et al., 2010). The most common and widespread hantavirus across northern, central 
and eastern Europe is PUUV, which is associated with the mildest form of HFRS 
(Vaheri et al., 2012). As described in Chapter 4, a new hantavirus, Tatenale virus 
(TATV) has now been added to this list. 
 
The Norwegian/brown rat (Rattus norvegicus) is the principal reservoir host for 
Seoul virus, a cause of mild to moderate HFRS disease in humans (Vaheri et al., 
2012). Brown rats are a cosmopolitan species and thus provide the potential to 
spread SEOV worldwide. SEOV specific antibodies have been detected in wild rats 
in Belgium (Heyman et al., 2009a), France (Heyman et al., 2004), Northern Ireland 
(McCaughey et al., 1996), Portugal (Filipe et al., 1991) and most recently the UK 
(Humber region) (Jameson et al., 2013a). Within Europe, human SEOV cases have 
mainly been associated with laboratory acquired infections (Shi et al., 2003), 
however there has been one confirmed HFRS case where SEOV RNA had been 
detected in a patients serum in Lyon, France (Macé et al., 2013). There have also 
been a further three presumed SEOV human cases in the UK with either suspected or 
known exposure to SEOV infected rats (Humber, North Wales and Oxfordshire) 
(Jameson et al., 2013a; Jameson et al., 2013b) and a single case confirmed 
serologically by virus neutralisation assay (vNA) in Lyon, France (Lundkvist 
personal comment; (Heyman et al., 2004)). Since 1983 there have been a number of 
unconfirmed suspected hantavirus reports in the UK where either SEOV or HTNV 
antibodies were found in both humans and rodents or if antibodies were not specified 
then exposure to rats was reported, all proposing the presence of SEOV in UK brown 
rats (Coleman, 2000; Davies et al., 1988; Lloyd, 1991; McCaughey et al., 1996; 
McKenna et al., 1994; Pether & Lloyd, 1993; Rice et al., 1993; Stanford et al., 1990; 
Thomas et al., 1999; Walker et al., 1984; Watson et al., 1997; Webster & 
Macdonald, 1995). Unfortunately no virus was isolated from these cases, making 
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these reports difficult to validate. This evidence suggests SEOV introduction into the 
UK may not have been a recent event.  
 
The presence of zoonoses in domestic pets is a cause for great concern as the risk to 
humans would be significantly greater. In China and the USA there have been 
several reports of hantavirus specific antibodies being detected in domestic pets 
(Childs et al., 1987; Leighton et al., 2001; Malecki et al., 1998). In Europe, PUUV 
antibodies have been found in domestic cats (16.9 %) and dogs (4.9 %) in Belgium 
(Dobly et al., 2012) and cats (5 %) in Austria (Nowotny, 1994; Nowotny et al., 
1994). HTNV antibodies have been detected in UK healthy (9.6 %) and chronically 
ill cats (23 %) (Bennett et al., 1990), but due to cross-reactivity amongst Murinae-
associated hantaviruses, this may indicate to the circulation of SEOV rather than 
HTNV. However it is thought that cats and dogs do not play a role in the 
maintenance and transmission of hantaviruses and most likely represent dead end 
hosts and spill over events (Dobly et al., 2012). The only instance where they may 
pose a risk to humans is in the exception of domestic pets bringing infected rodents 
into homes into closer proximity to humans. Pet rats on the other hand are a more 
likely route of transmission. In 2013, following a suspected human case in North 
Wales, a strain of SEOV designated „Cherwell‟ was isolated from a pet rat of the 
patient (Jameson et al., 2013b). This is the first confirmation of hantaviral RNA in a 
domestic pet and led to the subsequent investigation into the breeding colony where 
that pet rat had originated 
 
Fancy (pet) rats (Figure 7.1) originated in Europe in the 19
th
 century from the 
domestication of wild Rattus species in particular brown rats (R. norvegicus). Whilst 
fancy rats are not genetically different enough to be classified as a separate species, 
since domestication they have changed considerably in terms of their behaviour and 
physiology compared to wild counterparts. A 2012 survey by the Pet Food 
Manufacturers Association (PFMA) estimated there to be at least 200,000 pet rats 
within the UK. In general, pet rats are not thought to pose any more of a health risk 
than other common pets. However this recent finding suggests otherwise. Detection 
of SEOV in a pet rat raises the question of its origin and whether it has been 
naturally maintained in pet rats or recently introduced. 
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          Figure 7.1. Fancy rat (R. norvegicus) 
 
 
This study aimed to determine the proportion of pet rats from the breeder‟s colony 
that were infected with hantaviral RNA and provide evidence to assist in 
understanding the human health risk.  
 
7.3 Methods 
Samples 
The owner‟s consent was obtained to euthanase the 21 pet rats (R. norvegicus) from 
their breeding colony in Oxfordshire and remove them for further testing at the 
Animal Health and Veterinary Laboratories Agency (AHVLA) and The University 
of Liverpool (UoL). Lung and kidney material were removed from all animals and 
the carcases were stored at -80 °C. Heart, liver, salivary gland and spleen were also 
removed from one individual 3784. 
 
RNA extraction 
50-100 mg of liver tissue was homogenised in 1 ml TRIzol® Reagent (Invitrogen, 
Life Technologies, Paisley, UK) with QIAGEN Stainless steel beads (5 mm) using a 
QIAGEN TissueLyser (Qiagen, UK). RNA was extracted from the homogenate as 
described in the Invitrogen TRIzol® Reagent instructions for animal tissues 
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(Invitrogen, Life Technologies, Paisley, UK). RNA was quantified using a 
NanoDrop ND-1000 spectrophotometer (LabTech International, UK) and stored at -
80 °C until reverse transcription. 
 
cDNA synthesis 
RNA was reverse transcribed following a standard first strand cDNA synthesis 
protocol (Invitrogen, Life Technologies, Paisley, UK). Briefly, approximately 1 µl of 
RNA was reverse transcribed in a 20 µl reaction containing 50 ng/µl random 
hexamers, 10 mM dNTP mix (10 mM each of dATP, dGTP, dCTP and dTTP at 
neutral pH), 5X First strand buffer, 0.1 M DTT, 40 U RNaseOUT and 200 U 
SuperScript™ III Reverse Transcriptase (Invitrogen, Life Technologies, Paisley, 
UK). Cycling parameters were 65 °C for 5 mins, 50 °C for 50 mins and 85 °C for 5 
mins. The cDNA was stored at -20 °C. 
 
Hantavirus PCR 
Screening of the rodent lung samples for hantaviral RNA was performed using a 
nested pan-hantavirus PCR directed against partial polymerase (L) gene sequences 
(Klempa et al., 2006). Briefly, 2 µl cDNA was synthesised in a 14.5 µl reaction 
containing 75 mM Tris-HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01% (v/v) Tween 20, 
0.2 mM each dNTP, 1.5 mM MgCl2, 0.025 U Taq polymerase (ABgene) and 10 
pmol (each) of HAN-L-F1 and HAN-L-R1 primers (Eurofins MWG Operon, 
Germany) (Klempa et al., 2006). Cycling parameters were 95 °C for 15 mins, 40 
three step cycles (30 s at 95 °C, 45 s at 53 °C, 30 s at 72 °C) and at 72 °C for 6 mins. 
 
Primers HAN-L-F2 and HAN-L-R2 were used in the second round PCR (Eurofins 
MWG Operon, Germany) (Klempa et al., 2006). Thermal cycling conditions are as 
described above. Five µL of PCR product were analysed by 1.5 % agarose gel 
electrophoresis (120 V for 70 mins). Hantavirus positive samples gave a band at 
approximately 452 bp after the first round and 390 bp after the second round. 
Samples were repeated at two locations, UoL and AHVLA. 
 
cyt b PCR 
Morphological species determination of small mammals was confirmed by 
molecular identification using degenerate cyt b primers (Schlegel et al., 2011). 
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Briefly, 1 µl cDNA was PCR-amplified in a 14.5 µl reaction containing 75 mM Tris-
HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01 % (v/v) Tween 20, 0.2 mM each dNTP, 1.5 
mM MgCl2, 0.025 U Taq polymerase (ABgene) and 10 pM of the CytB Uni fw 
primer and CytB Uni rev primer (Eurofins MWG Operon, Germany) (Schlegel et al., 
2011). Cycling parameters were 94 °C for 3 mins, 40 three step cycles (30 s at 94 °C, 
30 s at 47 °C, 1 min at 72 °C) and 72 °C for 10 mins. PCR product was analysed by 
1.3 % agarose gel electrophoresis (120 V for 60 mins). Successful amplification of 
the cyt b gene gave a band at approximately 946 bp. 
 
PCR product purification and DNA Sequencing 
Primers and unincorporated nucleotides were removed from PCR products using an 
ExoSAP digest. Five µl PCR product was added to 2 µl mix containing 10X RX 
buffer, 0.2 U Shrimp Alkaline phosphatase (USB, UK) and 1 U Exonuclease I (New 
England BioLabs, UK). Cycling parameters were 37 °C for 45 mins, 80 °C for 15 
mins. The cycle sequencing reaction was set up using the BigDye® Terminator v3.1 
Cycle Sequencing kit. One µl of ExoSAP product was added to a 9 µl reaction mix 
containing 5X sequencing buffer, 0.75 µl BigDye 3.1 (Applied Biosystems, Life 
Technologies, Paisley, UK) and 1.6 pM of either LV forward, LV reverse, CytB Uni 
fw or CytB Uni rev primer. Cycling parameters were 25 three step cycles (96 °C for 
10 sec, 50 °C for 5 sec, 60 °C for 4 mins). The sequencing product was then 
precipitated using 3 M sodium acetate prior to resuspension in HiDi™ formamide 
(Applied Biosystems, Life Technologies, Paisley, UK), and then run on an 
ABI3130xl. 
 
Phylogenetic analysis 
Multiple amino acid sequence alignments were generated in MEGA5 (Tamura et al., 
2011). Sequence identities were compared using Geneious 5.6.5 (Biomatters: 
www.geneious.com, date accessed: 1/8/12). Maximum likelihood phylogenetic trees 
were produced in MEGA5 (Tamura et al., 2011) with bootstrap replications of 
10,000 (Felsenstein, 1985). Optimum substitution models were estimated in MEGA5 
(Tamura et al., 2011). 
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7.4 Results 
Screen 
Screening of pet rat lung and kidney samples for the presence of Seoul hantavirus 
RNA showed an overall prevalence of 81 % (17/21) (Table 7.1). Of the pet rats 
14/21 were found to be infected in the lung, 15/21 in the kidney and 12/21 in both 
(Table 7.1). Discrepancies between results are most likely due to low viral loads. 
 
Of the single individual 3784 from which multiple organs were sampled, SEOV 
RNA was detected in the heart, kidney, lung, salivary gland and spleen but not in the 
liver. 
 
Phylogenetic analysis 
Partial hantavirus L segment was retrieved from the RT-PCR of ten of the 17 
infected individuals (366 bp). All were 100 % identical and on blasting had greatest 
identity to Seoul strain Humber (97 %) which was recently isolated from UK wild 
rats (Jameson et al., 2013a). Phylogenetic analysis of the SEOV-positive pet rat 
shows it clustering with the Humber strain with moderate bootstrap support of 58 
(Figure 7.2). 
 
Partial sequences of the cyt b gene (833 bp) were recovered from 18 of the 21 pet rat 
samples, 16 infected samples and two non-infected samples. Seven variable sites 
were located within this partial sequence. Pairwise comparisons among all sequences 
(including out groups) ranged from 0 to 12 %. All pet rat cyt b sequences in this 
study had an average genetic distance of 0.5 % (ranging between 0.1 to 0.8 %) and 
compared to wild UK rats an average genetic distance of 0.8 % (ranging between 0.4 
to 1.3 %). Compared to brown rats worldwide (excluding individuals from 
mountainous areas of China, Lin et al., 2012) the pet rat sequences had an average 
distance of 0.7 % (range between 0 to 2.0 %). The average genetic distance to the 
outgroup R. tanezumi and R. rattus was 11.1 % (ranging from 10.7 to 12 %). All 
partials assembled randomly amongst R. norvegicus sequences (Figure 7.3).  
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Table 7.1. Hantavirus RT-PCR results for the 21 pet rats (R. norvegicus) screened at 
two separate locations (UoL and AHVLA). 
 
    Hantavirus RT-PCR Result   
  
UoL AHVLA 
 Sample Gender Lung Kidney Lung Kidney Result 
3776 Female Neg. Neg. Neg. Neg. Neg. 
3777 Female Pos. Pos. Pos. Pos. Pos. 
3778 Female Pos. Neg. Neg Neg. Pos. 
3779 Female Neg. Pos. Neg. Pos. Pos. 
3780 Female Pos. Pos. Neg. Pos. Pos. 
3781 Female Pos. Pos. Pos. Pos. Pos. 
3782 Female Pos. Pos. Pos. Pos. Pos. 
3783 Female Neg. Pos. Neg. Pos. Pos. 
3784 Male Pos. Pos. Pos. Pos. Pos. 
3785 Female Pos. Pos. Pos. Pos. Pos. 
3786 Female Neg. Neg. Neg. Neg. Neg. 
3787 Male Pos. Pos. Pos. Pos. Pos. 
3788 Female Neg. Neg. Neg. Neg. Neg. 
3789 Female Pos. Pos. Pos. Pos. Pos. 
3790 Male Pos. Pos. Pos. Pos. Pos. 
3791 Male Neg. Pos. Neg. Pos. Pos. 
3792 Female Pos. Pos. Pos. Pos. Pos. 
3793 Male Pos. Pos. Pos. Pos. Pos. 
3794 Female Neg. Neg. Neg. Neg. Neg. 
3795 Male Pos. Pos. Pos. Pos. Pos. 
3796 Female Pos. Neg. Pos. Neg. Pos. 
Pos. = Positive, Neg. = Negative 
    
 
 
 
 
 
 
 
 
 
 
 
  
120 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2. Maximum likelihood phylogenetic tree using model T92+Gamma 
(Tamura, 1992) for SEOV partial L segment sequences n = 20 in the MEGA5 
(Tamura et al., 2011) package of software with bootstrap of 10,000 (Felsenstein, 
1985). The trees are drawn to scale, with branch lengths measured in the number of 
substitutions per site. The scale bar indicates amino acid substitutions per site. Only 
bootstrap support of >70 % are shown. Positions with less than 95 % site coverage 
were eliminated. There were a total of 318 positions in the final dataset. The 
phylogenetic position of the UK pet rat is shown in relation to representative Seoul 
virus strains. Genbank accession numbers are shown next to taxa names. 
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Figure 7.3. Maximum likelihood phylogenetic tree using model HKY+Gamma 
(Hasegawa et al., 1985) for partial cyt b segment sequences n = 77 in the MEGA5 
(Tamura et al., 2011) package of software with bootstrap (continued overleaf). 
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Figure 7.3 continued. of 10,000 (Felsenstein, 1985). The trees are drawn to scale, 
with branch lengths measured in the number of substitutions per site. The scale bar 
indicates amino acid substitutions per site. Only bootstrap support of >70 % are 
shown. Positions with less than 95 % site coverage were eliminated. Positions with 
less than 95 % site coverage were eliminated. There were a total of 833 positions in 
the final dataset. The phylogenetic position of the UK pet rats are shown in relation 
to representative R. norvegicus sequences. Genbank accession numbers are shown 
next to taxa names.  
 
 
7.5 Discussion 
Domesticated rats are not generally considered a public health problem. However we 
have found that a large proportion (81 %) of rats from a breeder‟s colony were 
infected with Seoul virus. Coupled with the recent human cases associated with the 
pet rats, hantaviruses may pose a greater public health risk than previously believed. 
 
SEOV RNA was detected in 5/6 organs tested for the one individual 3784, including 
the salivary glands which have previously been shown to be a source of direct 
transmission between rats during aggressive encounters (Glass et al., 1988). The 
liver did not yield viral RNA, although the individual may have had low viral loads 
in this sample. The liver was checked for inhibitors that could have affected the 
PCR. However detection of the cyt b gene confirmed this not to be the case. 
 
Further analysis of partial L sequence retrieved from the RT-PCR shows it to be 97 
% identical to the Humber strain, situated alongside it in the partial L segment tree 
(Figure 7.2). No L sequence was available for comparison from the recently 
described Cherwell strain that was isolated from the pet rat in North Wales (Jameson 
et al., 2013b). The fact that this strain is so close to the wild UK strain raises 
questions as to the source of this virus; has it always been within the domestic rat 
communities or has recent contact been made with an infected UK rat? Whilst there 
have been no previously detected hantaviruses in pet rats, other UK studies have 
provided unconfirmed evidence for the circulation of SEOV in wild brown rats since 
at least the early 1980‟s (Walker et al., 1984). 
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The cyt b gene can not only be used for species identification but can also provide 
information on the relative genetic differences between a species. Based on cyt b 
analysis, the average genetic distances between pet rats and wild UK rats was 0.8 %, 
greater than that seen between pet rats and wild brown rats worldwide (0.7 %). The 
range however was larger when compared to brown rats worldwide. Also 
phylogenetic analysis of pet rats does not show any specific deviation from wild 
brown rats suggesting they are not that different (Figure 7.3). 
 
Fancy rat hobbyists include a large network of individuals throughout the UK that 
meet up regularly for competitions and other social occasions. Such gatherings could 
give rise to possible transmission events; for example the transfer of virus 
contaminated urine and faeces between cages. There have been guidelines published 
by AHVLA and HPA on the safety precautions against hantaviruses to minimise the 
health risks to owners of pet rats (HPA, 2013). 
 
We present here confirmation of the presence of Seoul virus RNA in a high 
proportion of rats from a breeding colony in Oxfordshire, UK. Sequence analysis of 
the partial L segment confirms it to be most similar to the recently isolated UK wild 
SEOV strain (Humber) and questions the origin and distribution of UK SEOV. We 
also demonstrate the widespread distribution of SEOV viral RNA in the majority of 
samples taken from a single individual including the salivary glands indicating 
another potential route for transmission. Further screening is required to determine 
the prevalence of SEOV in other breeding colonies around the UK. Until then safety 
precautions recently published should be followed to minimise the health risk to pet 
rat owners as well as transmission between pet rats. 
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Chapter 8. General Discussion 
 
Zoonoses constitute the majority of infectious organisms that are known to be 
pathogenic to humans (Taylor et al., 2001). They are not only a public health 
concern but also represent a considerable economic burden. More than 20 % of 
zoonotic pathogens are reported to have rodents as hosts (Cleaveland et al., 2001). 
The order Rodentia represent an abundant and diversified order of mammals 
(Meerburg et al., 2009), that can be found inhabiting most habitats, have the 
potential to get in close proximity to humans, and represent a link between wildlife 
communities and humans. The primary aim of this thesis was the targeted 
surveillance for hantavirus and Ljungan virus in rodent species from a range of 
habitats in the North West UK. Data from this study has also been applied to draw 
conclusions on rodent-borne zoonoses in the UK in general. 
 
In 2011, Defra reported five zoonoses as currently circulating in the UK that are 
associated with rodents, bovine tuberculosis, cryptosporidiosis, HFRS, leptospirosis 
and Lyme disease (Defra, 2012). Whilst this figure may seem a fraction of the 
potential rodent-borne zoonoses that are known around the world (Meerburg et al., 
2009), it is by no means conclusive as more zoonotic pathogens are constantly 
emerging (Daszak, 2000) and as such can only be corroborated through further 
surveillance. Surveillance is important not only to gain insights into what is out there 
but also to assess the likely risks there might be to humans. Evidence of hantavirus 
circulation had been reported since 1983 (McCaughey & Hart, 2000; Walker et al., 
1984) but confirmation of a responsible agent did not follow. Hantaviral species can 
be difficult to distinguish due to detectable viraemia generally only being present in 
low levels in the acute phase of infection (Plyusnin et al., 1997a) and also because 
hantaviruses exhibit cross-reactivity between closely related species. Whilst it is 
important to know the hantaviral agent responsible, there is currently no species 
specific treatment available and management tends to be on a case by case basis. It 
was only in 2012 following targeted hantavirus surveillance, that SEOV was first 
detected in wild brown rats in the UK (Jameson et al., 2013a) and a novel hantavirus, 
Tatenale virus (TATV) was detected in a rural field vole in Cheshire (Chapter 5, this 
study). This highlights the benefits of fully investigating potential zoonotic episodes 
to appropriately evaluate the public health risk. 
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The main limiting factor in surveillance programmes, including this study, is one of 
resources, particularly financial. Whilst a comprehensive trapping and sampling 
programme for urban and rural rodents throughout the UK would provide better 
confidence in prevalence data, the financial costs of such a scheme are prohibitive.  
As the limited resources available were likely to impact on the outputs of the project, 
Defra provided us with a budget to hold a workshop in Liverpool. We invited 
international hantavirus experts from across Europe and the USA to advise us of the 
optimal field and laboratory approaches. The strategy of sampling and pan-
hantavirus RT-PCR screening employed in this project were agreed at this workshop. 
The primary focus for surveillance was urban rodents, which resulted in the rural 
species e.g. bank voles and field voles, being under represented. Larger sample sizes 
would be necessary in the species tested in this project to have more confidence in 
the absence of either virus or the low prevalence and thus risk posed to humans. It is 
estimated that we would require sample sizes of approximately 60 or 300 to be 
convinced of detecting virus prevalence of 5 % or 1 %, respectively, at the 95 % 
confidence level. Also, hantaviruses have recently been detected in non-rodent 
species, such as bats and shrews (Klempa et al., 2007; Weiss et al., 2012), that were 
not sampled in this project but may in fact be carriers for other hantaviruses 
circulating in the UK and thus should be investigated. With regards to LV 
surveillance we found no evidence of LV in rodents collected for this study even 
though virus has previously been reported elsewhere in the UK (Salisbury et al., 
2013). Furthermore due to sensitivity and specificity validation of our hemi-nested 
RT-PCR using positive material provided by collaborators, we are confident that our 
assay would have detected LV if it were present in our samples. 
 
Domesticated rats have generally been separate from their wild counterparts since 
the 19
th 
century and have been largely regarded as no particular health concern for 
humans. Although the transmission of zoonotic pathogens between pet rodents and 
humans is rare, there have been several reported cases where it has occurred 
(Chomel, 1992), including lymphocytic choriomeningitis virus (Amman et al., 
2007), cowpox virus (Ninove et al., 2009), hantavirus (Jameson et al., 2013a), 
Spirillum minus (Shvartsblat et al., 2004) and Leptospira (Baer et al., 2010). 
However, we have shown that the „clean‟ image of pet rats should possibly be re-
thought as a large proportion (81 %) of fancy rats in a breeding colony in 
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Oxfordshire were infected with Seoul virus (Chapter 7). Investigation of more 
breeding colonies would be required to determine the extent of prevalence 
geographically or if it happens to be a localised event. An anonymous surveillance of 
pet rats is planned by the Animal Health and Veterinary Laboratories Agency 
(AHVLA) and Public Health England (PHE). 
 
Hantaviruses and Ljungan virus are but two zoonoses carried by rodents. It has been 
previously shown that rodents can be reservoirs for an array of pathogens as 
illustrated in brown rats (R. norvegicus) around the world and here in the UK 
(Adjemian et al., 2008; Easterbrook et al., 2007; Glazebrook et al., 1978; Webster & 
Macdonald, 1995). As an output from this project through collaborations, our 
hantavirus infected field vole was also found to be infected with Leptospira (Chris 
Ball, pers. comms.), and Capillaria hepatica found in several urban brown rats 
(Appendix 1, McGarry, Manuscript in Prep), both serious zoonoses (Bhattacharya et 
al., 1999; Ellis, 1999). Rodent samples from our urban surveillance, have been 
provided to Nottingham University (as part of the FP7 WildTech project) for the 
purpose of microarray validation to detect and identify infectious agents in rodent 
populations. This is an example of the sharing of rodent samples from the North 
West UK through collaborations to get a better understanding of the zoonotic 
pathogens actually carried by these otherwise healthy looking rodents (Appendix 1). 
Without other such exchanges from different areas of the UK we are at best likely to 
obtain only a patchy overview of rodent-borne zoonoses. 
 
Many zoonoses originate from wildlife species (Cleaveland et al., 2001; Kruse et al., 
2004) so it might be speculated that urban rodent populations may pose a lower risk 
to humans despite a higher transmission risk due to the close proximity. For the most 
part evidence presented in this thesis would support this as we found no evidence of 
HV or LV in urban rodents in Liverpool, and the novel hantavirus was detected in a 
rural rodent (Chapter 5). However the Lyon study (Chapter 6) contrasts this as 14 
SEOV infected urban and four rural brown rats were found. This may be more 
attributable to the fact that SEOV, carried by members of the Rattus sp., distribution 
is known to be mediated by human travel e.g. boats, and as such are more likely to 
be associated with urban areas. Other zoonotic pathogens such as Bartonella, 
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Coxiella and Rickettsia have also been shown to be maintainable in urban areas 
(Comer et al., 2001).  
 
Whilst this thesis has focused primarily on rodents as sources of zoonoses and a 
cause for concern, it must not be forgotten that the picture is mirrored in that of other 
animal orders, which in some cases are reported to have the potential to harbour 
greater proportions of zoonotic pathogens than rodents e.g. ungulates and carnivores 
(Cleaveland et al., 2001). Non-rodent species that predate on rodents can also be 
useful in potentially acting as sentinels for disease systems. There have been several 
examples of where the surveillance of sentinel species such as cats, dogs, foxes and 
owls have been shown to predict the risk of hantaviruses to the human population 
(Dobly et al., 2012; Escutenaire et al., 2000; Heyman et al., 2013). Companion 
animal (cats and dogs) sera samples were available through the pet travel scheme for 
this study, however resources did not allow for them to be serologically tested. As 
such it should be ensured that surveillances cover all animal orders to get a more 
complete assessment of zoonoses in the UK. 
 
Next generation sequencing (NGS) is a relatively novel technique that has many 
applications in research especially virology. Its usefulness mainly comes as a result 
of the vast amount of information it can produce in a small amount of time, and with 
currently financial constraints being the only main drawback which will inevitably 
cease as technology improves and becomes more popular (Radford et al., 2012). The 
benefits of NGS application is most apparent when dealing with epidemics (Radford 
et al., 2012). These specifically require a faster response in order to ascertain 
treatment, control and preventative measures against the causative agent. Whilst the 
genome sequences obtained in Chapter 4 were not received as a consequence of an 
epidemic but instead were for the academic purpose of characterising two further LV 
genomes, it provides a good example of the value of NGS. A limitation found in the 
analysis of these full LV genomes was however the lack of availability of any 
sequence information from spatially and/or temporally separate isolates despite the 
virus being reported in different locations and years. In the case of LV (Chapter 4), it 
may have supported or contested the finding of LV exhibiting surprisingly slow 
evolution for a picornavirus. Examples where NGS have already been valuable 
include the molecular epidemiology of foot-and-mouth disease outbreaks in the UK 
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(Knowles & Samuel, 2003), rapid identification of a novel arenavirus in South 
Africa within 72 hours of receiving samples (Briese et al., 2009), a yellow fever 
virus outbreak in Uganda (McMullan et al., 2012), Schmallenberg virus in Europe 
(Hoffmann et al., 2012), characterisation of an E. coli outbreak within 62 hours 
(Mellmann et al., 2011) and of the 2009 influenza A pandemic (Kuroda et al., 2010). 
Of the list of notifiable zoonoses in the UK (www.defra.gov.uk/animal-
diseases/notifiable, date accessed 1/2/13), avian influenza, bovine spongiform 
encephalopathy, bovine tuberculosis and European bat lyssavirus have been reported 
since 2008. The risk from newly emerging zoonotic outbreaks in the UK might seem 
insignificant but this may be due to the resources that are spent to control and 
prevent outbreaks (Corry & Hinton, 1997; de la Rua-Domenech, 2006; Westrell et 
al., 2009). Realistically, we should focus our attention on those zoonoses that are 
circulating within the UK as they have the potential to impact on our health and the 
economy. With this NGS technology, we are now fully equipped to act upon the first 
signs of an outbreak as well as pre-empting future outbreaks and emerging 
pathogens. 
 
Whilst obtaining full genomes are often the goal for many pathogens, sequence 
marker information from the host can be just as useful for understanding the 
dynamics of the virus and its host. In Chapters 5, 6 & 7, the mitochondrial 
cytochrome b (cyt b) gene, a gene used for the purpose of species identification 
(Bradley & Baker, 2001) was used to infer if non-indigenous brown rats had been 
introduced into the UK and that may provide an explanation to the presence of 
SEOV. In this study we found divergences of 0.3 % between SEOV infected and 
non-infected brown rats from around Lyon, 0.6 % between Lyon rats and UK brown 
rats (Chapter 5) and 0.8 % between UK and pet rats (Chapter 6). These low 
divergences were very similar regardless of their country of origin, infection status 
or domestication, thus making it difficult to distinguish within species differences. A 
limitation was that only partial sequences were obtained, although this did 
correspond to approximately 73 % of the entire cyt b gene, but also differences may 
not be associated with that particular region of the mitochondria. Whilst useful for 
species identification, instead perhaps other potential markers, nuclear or 
mitochondrial could be used instead to compare and improve the resolution within a 
species. Although two reports have shown the cyt b gene from R. norvegicus and R. 
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rattus to be sufficient in determining genetic diversity on a global scale (Aplin et al., 
2011; Lin et al., 2012), it was inadequate to detect differences within species in this 
study to highlight the potential introduction of non-indigenous individuals to the UK. 
A literature search turned up no other markers commonly used for phylogenetic 
analysis of rodents. 
 
Whether it be whole genome (Chapter 4) or partial sequences (Chapters 5, 6 & 7) it 
seems clear from this study that all should be obliged to publish their sequence data 
for research to progress.  
 
Conclusions 
This study aimed to primarily assess the presence and prevalence of two zoonotic 
viruses carried by rodents, in the North West UK, so as to provide assistance in 
assessing the relative human risk. In addition, this study 1) characterised two new 
LV isolates using next generation sequencing techniques, and 2) in collaboration 
with the FP7 WildTech project determined the prevalence of hantaviral RNA in 
urban brown rats from Lyon, France and 3) in collaboration with AHVLA and HPA 
determined the prevalence of hantaviral RNA in a breeding colony of pet rats. The 
results revealed no evidence of Ljungan virus circulating in North West UK rodents 
(Chapter 2). The characterisation of two new Swedish LV isolates exhibited no 
significant variations from the current five genomes available although only small 
amounts of positive selection was found, a characteristic unusual for RNA viruses 
(Chapter 3). Hantavirus surveillance resulted in the detection of a novel virus, 
Tatenale virus, in a field vole (Chapter 4). This study also revealed that a proportion 
of brown rats from Lyon (14.1 %) and pet rats (81 %) from a breeding colony were 
infected with SEOV hantaviral RNA (Chapter 5 and Chapter 6). Moreover, I 
demonstrated that the application of next generation sequencing techniques can be 
used to obtain full RNA viral genome sequences for genomic characterisation 
(Chapter 3 and Chapter 5) and molecular methods for the successful surveillance of 
RNA viruses in wild and domestic rodents (Chapter 2 and Chapter 4).  
 
In summary, these findings provide new evidence for the circulation of hantaviruses 
and Ljungan virus in UK and domestic rodents, and as such has also highlighted the 
importance for the continued investigation of zoonoses in the UK. 
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